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ABSTRACT
WISEWOMAN (WW) is a comprehensive program for medically underserved women in
South Dakota (SD), aged 30 to 64, which aims to reduce morbidity and mortality from
chronic diseases. Screening services include blood total cholesterol, blood pressure and
blood glucose, and body mass index (BMI). Lifestyle intervention (LSI) sessions are also
offered to address physical activity and nutrition. The purpose of this retrospective
longitudinal study was to quantitatively examine whether the combination of LSI’s and
clinical screenings or clinical screenings alone lead to improvements in blood pressure,
blood glucose, total cholesterol, and/or BMI at rescreening 10 to14 months from initial
screening. Guided by the social ecological model ,it was hypothesized that SD-WW
participants attending the screening sessions as well as the intervention sessions would
have greater reductions in blood pressure, total cholesterol, and blood glucose than
participants who only received screenings. Participants included 653 low-income women
aged 30 to 64 enrolled in the screening alone (N=423) and SD-WW program (N=230)
from 2000-2005, who completed both the screening and rescreening 10 to14 months
later. Secondary data analysis using forced-entry multiple regression of the traditional
measures employed in the screening alone control condition yielded significant predictive
models for change scores in blood pressure, BMI, blood glucose, and cholesterol among
all participants. Neither dummy variable regression nor ANOVA results indicated any
significant impact of the SD-WW intervention on these same health outcome changes.
Findings contribute to positive social change by demonstrating that screening alone is
effective in predicting health outcomes, thus allowing more disadvantaged women to be
served by public agencies that may face reduced funding for their array of programs.
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CHAPTER 1
INTRODUCTION TO THE STUDY
Introduction
Heart disease is the leading cause of death for South Dakota women, accounting
for 24.7% (n = 865) of all deaths in this group during 2006. Congestive heart failure in
South Dakota mirrors the national rate. The age-adjusted rate of congestive heart failure
in South Dakota women was 131.5 out of 100,000 (SD Vital Statistics Report, 2006),
while the age-adjusted rate among women in the United States was 131.2 out of 100,000
(Centers for Disease Control [CDC], 2006). Among deaths from congestive heart failure
in the state since 2002, 60% were women (SD Vital Statistics Report, 2006).
Among all female adults 18 and older in South Dakota, 3.2% reported having
experienced myocardial infarction (a heart attack) in 2006 (CDC, 2006). Education level
was a significant predictor of heart attack risk factor among South Dakota women: 8.4%
of women with eighth grade or less education report having a heart attack compared with
1.8% of women with a college degree. Approximately 3% of South Dakota women have
angina or coronary heart disease (CDC, 2006). Heart disease prevalence decreases as
education level increases. Women with a college education were less likely to report
diagnosis of coronary heart disease than women with an 8th grade or less education (2.1%
vs. 7.8%; CDC, 2006). South Dakota’s crude rate of coronary heart disease among
women, is higher (179.7 / 100,000) than the United States average (163.7 / 100,000).
Trends in several major risk factors for cardiovascular disease are discouraging.
In 2006, 19.1% of female respondents to South Dakota’s Behavioral Risk Factors
Surveillance System (CDC, 2006) survey stated they were current cigarette smokers.
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Cigarette smoking is three times more common among American Indian women than
White women (50.4% vs. 16.3%). Of South Dakota WISEWOMAN enrollees, 37%
smoke; this is the highest incidence of smoking reported by any of the 15 currently
funded WISEWOMAN projects. The percentage of the female population that is
overweight and obese has increased dramatically over the past decade. In 2006, 54.7% of
female South Dakotans were overweight or obese (Behavioral Risk Factor Surveillance
System [BRFSS], 2006). Obesity is most prevalent among American Indian women:
77.1% are overweight or obese. Nationally, 61.8% of women are overweight or obese.
About one quarter (24%) of all BRFSS respondents do not participate in any leisure-time
physical activity. This risk factor is also more prevalent among American Indians
females, of whom 38% report participating in no leisure-time physical activity, that is
respondents that report no leisure time physical activity or exercise during the past 30
days other than the respondent’s regular job. Nationally, 22% of all BRFSS respondents
participate in no leisure-time physical activity.
In 2005, only 25% of women in South Dakota reported consuming at least the
recommended five servings of fruits and vegetables per day (BRFSS, 2005). Nationwide,
the rate is somewhat lower at 23.2%, a small but statistically significant difference (CDC,
2006). In 2005, 25% of women in South Dakota reported high blood pressure (SD
BRFSS, 2005). Prevalence of hypertension among American Indian and White females is
relatively similar (25.8% vs. 25%). Approximately one third (32.6%) of female BRFSS
respondents indicated having been diagnosed with high blood cholesterol levels. There
was no significant difference between American Indian women and White women
(32.4% vs. 30.3%) in this risk factor.
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According to the CDC (2006), 6.5% of South Dakota female BRFSS
respondents reported having been diagnosed with diabetes. Diabetes is almost three times
as prevalent among American Indian females as among White females (16.7% vs. 6%).
Nationally, diabetes affects 7.5% of all women (CDC, 2006). Prevalence of diabetes
decreases as education level increases. Women with a college education are one fourth
more likely to report diagnosis with diabetes than women with an 8th grade or less
education (3.9% vs. 13.8%; CDC, 2006).
Cardiovascular disease and risk factors leading to cardiovascular disease
disproportionately affect American Indian women in South Dakota. Health disparities
among American Indian populations in South Dakota are complex phenomena that are
longstanding and require long-term commitment and comprehensive approaches.
Background
The Well-Integrated Screening and Evaluation for Women Across the Nation
(WISEWOMAN) is a comprehensive program for medically underserved women to
reduce morbidity and mortality from chronic diseases. WISEWOMAN is an extension of
the National Breast and Cervical Cancer Early Detection Programs (NBCCEDP) funded
by the CDC. Screening services include blood cholesterol, blood pressure, and blood
sugar. Nutrition and physical activity interventions are delivered through three individual,
one-on-one sessions with the interventionist, that are based on A New Leaf-Choices for
Healthy Living (University of North Carolina, 2001) and Active Living Every Day (Blair,
Dunn, Marcus, Carpenter, & Jaret, 2001). The New Leaf curriculum is based on the
transtheoretical model of behavioral change. The Active Living workbook was developed
by the Cooper Aerobics Center in Dallas, TX, based upon a successfully tested cognitive-
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behavioral approach to improving physical activity.
Theoretical Foundation
The WISEWOMAN project was founded on the transtheoretical model of
behavior change (Diclemente & Proschaska, 1983) and the health belief model (HBM)
(Simons-Morton, Greene, & Gottlieb, 1995). The transtheoretical model of behavior
change describes the five stages of behavior change in which individuals can enter and
exit stages at any given time. The five stages of change include precontemplation,
contemplation, preparation, action, and maintenance (Diclemente & Proschaska, 1983).
According to Simons-Morton et al., the HBM is a value-driven theory in that it attempts
to explain and predict health behaviors by focusing on the individuals desire to prevent
illness or rehabilitate from an illness. The core elements addressed by the HBM include
perceived threat, perceived sustainability, perceived severity, perceived benefits,
perceived barriers, cues to action, and self-efficacy.
The theoretical foundation for which this research project is based upon is the
socioecological model, which explains how individual behavior can be influenced at
multiple levels: individual, interpersonal, organizational, community, and public policy
(Institute of Medicine, 2003). The model combines individual behavior with social and
physical environments, while recognizing the level of self-responsibility that individuals
have to take for positive lifestyle change and the outside forces that influence individual
behavior. The socioecological model acknowledges the interwoven relationship between
the individual and their environment. The socioecological model explains how lifestyle
choices are individual choices made in the midst of the various environments in which
the individual is nested (Institute of Medicine, 2003). The WISEWOMAN program
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targets the individual and interpersonal levels by focusing on what motivates the
woman, while the interpersonal level is addressed in that the WISEWOMAN program
provides social support for the woman. Addressing these levels is an essential program
component, as they provide the fundamental support necessary for behavior change to
occur.
On September 30, 2000, the South Dakota Department of Health received funds
from the CDC’s WISEWOMAN program to integrate cardiovascular disease (CVD) and
diabetes screening services into the Department’s existing National Breast and Cervical
Cancer Early Detection Program (BCCEDP). The addition of the WISEWOMAN
program in South Dakota reduces morbidity and mortality resulting from chronic disease
among the medically underserved population. South Dakota’s BCCEDP program serves
women 30 to 64 years old. In order to create a system that is both patient and providerfriendly, the AWC! WISEWOMAN program also serves women aged 30 to 64. The
population of low-income women in South Dakota aged 30 to 64 is 39,823 (South Dakota
Department of Social Services, 2006).
The greatest need for WISEWOMAN services in the state is among low-income
women. Table one indicates the percentage of women without insurance by race. About
one in every ten South Dakota women (9.9%) is uninsured (N = 16,696).
Table 1
South Dakota Women Without Health Insurance by Race (CDC, 2006)
Race / Ethnicity

% of women without health insurance

American Indian
Hispanic
White
Total

1.10%
15.80%
10.20%
9.90%
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Statement of the Problem
Adoption and maintenance of health behavior change is a public health challenge,
particularly from those populations suffering from health disparities. While the quality of
life and chronic disease risk reduction benefits of healthy eating and regular physical
activity are well understood, the ability to promote adherence to a lifetime of these health
behaviors is limited (Institute of Medicine, 2001). The major problem is that while
intervention strategies that lead to adoption of healthy behaviors are well developed,
knowledge of how to facilitate sustained health behavior is not readily available in the
current body of research.
Cardiovascular disease and risk factors leading to cardiovascular disease
disproportionately affect women in South Dakota’s disparate populations. More research
is needed related to cardiovascular disease and its risk factors among low-income women
in South Dakota WISEWOMAN if health disparities are to be reduced..
Purpose of the Study
The purpose of this retrospective longitudinal study was to quantitatively examine
whether the combination of Lifestyle Intervention Sessions (LSI)sessions and clinical
screenings or clinical screenings alone lead to improvements in blood pressure, blood
glucose, total cholesterol, and/or body mass index (BMI) as measured at rescreening 10
to14 months from initial screening. This study provides information to the SD
WISEWOMEN program regarding the effectiveness of LSI support for clinical screening
as opposed to clinical screening to improve health. The results effect future program
implementation decisions and serve as a model of WISEWOMAN program evaluation
for the CDC.
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Research Questions and Hypotheses
The primary research questions that are addressed in this dissertation include:
1. Is the change in blood glucose level, as measured at rescreening 10 to14
months from initial screening, different for women enrolled in the South Dakota
WISEWOMAN program lifestyle intervention than women receiving clinical screening
only?
2. Is the change in BMI, as measured at rescreening 10 to14 months from initial
screening, different for women enrolled in the South Dakota WISEWOMAN program
lifestyle intervention than women receiving clinical screenings only?
3. Is the change in total cholesterol level, as measured at rescreening 10 to14
months from initial screening, different for women enrolled in the South Dakota
WISEWOMAN program lifestyle intervention than women receiving clinical screenings
only?
4. Is the change in blood pressure level, as measured at rescreening 10 to14
months from initial screening, different for women enrolled in the South Dakota
WISEWOMAN program lifestyle intervention than women receiving clinical screenings
only?
The primary research hypotheses addressed in this dissertation are:
1. Women attending at least one Lifestyle Intervention Session will experience a
larger reduction in blood glucose than women receiving only clinical screening as
measured at rescreening 10 to14 months from initial screening.
2. Women attending at least one Lifestyle Intervention Session will experience a
larger reduction in BMI than women receiving only clinical screening as measured at
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rescreening 10 to14 months from initial screening.
3. Women attending at least one Lifestyle Intervention Session will experience a
larger reduction in total cholesterol levels than women receiving only clinical screening
as measured at rescreening 10 to14 months from initial screening.
4. Women attending at least one Lifestyle Intervention Session will experience a
larger reduction in their blood pressure levels than women receiving only clinical
screening as measured at rescreening 10 to14 months from initial screening.
Definition of Terms
Participation in the South Dakota WISEWOMAN program: was defined
conceptually as either participation in the intervention sessions or participation in the
screening and rescreen at 10 to14 months. An operational definition for participation in
the South Dakota WISEWOMAN: according to the South Dakota WISEWOMAN
program (2008) is the enrollment of an uninsured/underinsured woman aged 30 to 64 in
the NBCCEDP program and All Women Count! (AWC!) chronic disease screening
program by the medical provider, at initial screening session. The dependent variables in
this dissertation study were BMI, total cholesterol, blood pressure, and blood glucose. In
order to measure each variable, an index of unique identifiers such as dates, interventions,
and rescreen results were made and then aggregate data was analyzed to determine if
change occurred.
High blood pressure: is defined as having systolic blood pressure equal to or
greater than 140 mmHg or diastolic blood pressure equal to or greater than 90 mmHg, or
taking medication for high blood pressure.
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High cholesterol: is defined as having total cholesterol equal to or greater than
240 mg/dl or taking medication for high cholesterol (CDC WISEWOMAN, 2005).
Overweight: is defined as having BMI of 25 to 29.9, while obese is defined as
having a BMI equal to or greater than 30. BMI is calculated using CDC standards: BMI =
(weight in pounds) divided by (ht in inches squared) times (703). Prediabetes is defined
as a fasting blood glucose of 100 to125mg/dl or a nonfasting glucose of 140 to 199 mg/dl
(CDC WISEWOMAN, 2005).
Diabetes: is defined as a fasting blood glucose equal to or greater than 126mg/dl
or a nonfasting glucose equal to or greater than 200 mg/dl or history of diabetes or taking
medication for diabetes (CDC WISEWOMAN, 2005).
Significance
The study findings will impact social change by elucidating whether health
outcomes among women who receive LSI sessions and screenings differ from women
who only receive the clinical screening and rescreening in improving blood pressure,
blood glucose, total cholesterol, and/or BMI. Understanding whether the more intensive
intervention (screening sessions along with LSI) has greater influence on biological
outcomes than the less intensive method (screening alone) will assist in the design of
more effective public programs aimed at improving the health in population groups
similar to those served in South Dakota. Since South Dakota’s WISEWOMAN program
includes a substantial number of at-risk women, the results of this study will be of value
to other states that have similar proportions of this disparate population.
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Assumptions
There is an absence of medication histories for each participant in this study. The
South Dakota Department of Health or MaxTrac chose not to include medications in the
MDE (minimal data elements) that it collects because all participants in need of
medications were referred to the Department of Social Services RX Access program.
Medications would influence the variable if they are at all efficacious. There is no reason
to believe, however, that medication use varied between women in the LSI groups and
women who received clinical screening only. It was also assumed that all participants
were South Dakota female residents that met the age and income requirements for
program enrollment. However, to assess this assumption age was examined in the data
analysis. It was also essential to assume that the lab results and measurements of blood
pressure, blood glucose, BMI, and total cholesterol were accurate. However, it is
recognized that there can be bias in self-reported health behaviors.
Limitations
Methodological issues in the sample for this research limited the external validity
of this study. Since clients were not randomly assigned to groups, unmeasured variables
confound the results. Another limitation of the study was the absence of medication
histories for each participant. The South Dakota Department of Health or MaxTrac chose
not to include medications in the MDE (minimal data elements) that it collects because
all participants in need of medications were referred to the Department of Social Services
RX Access program. American Indian data are lacking in this dissertation study because
of a simple billing issue. Indian Health Service (IHS) does not submit bills to the South
Dakota WISEWOMAN program for screening. If the program does not pay the bill, then
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the woman can not be enrolled in the WISEWOMAN program. This would appear to
be a straightforward problem to fix; however, it has been ongoing since the program
began.
Summary
Cardiovascular disease is the leading cause of death among women in South
Dakota. While cardiovascular disease is preventable, the adoption and maintenance of
healthy behavior change is not well understood. More research is needed to quantitatively
examine whether women enrolled in the lifestyle intervention sessions experience a
greater reduction in blood pressure, blood glucose, total cholesterol, and/or BMI as
compared to those women receiving only clinical screening, as measured at rescreening
10 to14 months from the initial screening.
Current research conclusions and recommendations within the literature are
reviewed and summarized in chapter 2. An exhaustive review of the literature yielded
significant data to provide a theoretical framework and validate the outcomes presented
in this dissertation. Research methodology and protection of human subjects will be
detailed in chapter 3. The results are presented in chapter 4. Lastly, the recommendations
and implications for social change are addressed in chapter 5.

CHAPTER 2:
LITERATURE REVIEW
Introduction
This chapter reviews and summarizes lifestyle interventions research studies. It
also reviews the researcher’s theoretical framework, empirical WISEWOMAN studies,
WISEWOMAN lifestyle interventions and the WISEWOMAN best-practices.
The Well-Integrated Screening and Evaluation for Women Across the Nation
(WISEWOMAN) is an extension of the National Breast and Cervical Cancer Early
Detection Programs (NBCCEDP) funded by the CDC. Screening services include blood
cholesterol, blood pressure and blood sugar. The LSI sessions offer women with elevated
or alert screening values (CDC WISEWOMAN, 2005) up to four lifestyle interventions.
The elevated value for blood pressure was classified as >140/90 but <180/110 mm Hg,
while an alert value was >180/110 mm Hg. The elevated value for total cholesterol was
>= 200 mg/dl, while the alert value was >= 400mg/dl. The elevated value for blood
glucose (Fasting Plasma Glucose Test) was >= 126mg/dl, while the alert value was >=
200 mg/dl. A BMI between 25 and 29.99 was classified as overweight, while a BMI of
30 or above was classified as obese.
The 39 AWC! interventionists meet with women in person, by phone, or through
self-study (by correspondence). The program is also developing web-based intervention
support services using popular new internet media and communication technologies to
reach out to its widely-distributed target population (South Dakota WISEWOMAN,
2008). Participating women complete rescreening between 10 and 14 months after
baseline screening. AWC! has provided WISEWOMAN services to one third of South
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Dakota’s BCCEDP-eligible women.
The remainder of this chapter reviews the theoretical framework that guides both
this study and the WISEWOMAN program. Evaluation studies published describing
WISEWOMAN projects are reviewed, and the limitations of those studies, and the
unanswered questions that will be addressed in this study.
Theoretical Framework
The theoretical framework on which the South Dakota WISEWOMAN
interventions are based includes the transtheoretical model of behavior change
(Diclemente & Proschaska, 1983) and the health belief model (Simons-Morton et al.,
1995). The theoretical foundation for which this research project is based upon is the
socioecological model (Institute of Medicine, 2003). The transtheoretical model may be a
key to impacting individual choices regarding lifestyle and health-related behaviors. The
transtheoretical model was developed in the late 1970s and early 1980s by Prochaska and
DiClemente at the University of Rhode Island. The transtheoretical model of behavior
change describes the five stages of behavior change in which individuals can enter and
exit stages at any given time. The five stages of change include precontemplation,
contemplation, preparation, action, and maintenance (Diclemente & Proschaska, 1983).
Using the transtheoretical model as a guide to individual behavior change, intervention
strategies can be formulated that will assist and motivate individuals to change their
lifestyles and make healthier choices. Lifestyle interventions are most effective when
they match the individuals’ readiness to change (Will & Loo, 2008). In the specific
program explored in this dissertation, women receive counseling messages that facilitate
their ability to advance from not thinking about healthy eating or physical activity
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(precontemplation stage) or thinking about healthy eating or physical activity
(contemplation stage) to taking small steps toward changing these health behaviors
(preparation stage). The ultimate goal is regularly eating a heart healthy diet and
participating in physical activity most days of the week (action stage). The assessment
form used by the WISEWOMAN program assists program staff in determining
interventions for each participant.
The health belief model (HBM) attempted to explain and predict health behaviors
by focusing on the individuals desire to prevent illness or rehabilitate from an illness
(Simons-Morton et al., 1995). The HBM theorized why people fail to initiate and sustain
positive change (Janz & Becker, 1984). The core elements addressed by the HBM
include perceived threat, perceived sustainability, perceived severity, perceived benefits,
perceived barriers, cues to action, and self-efficacy. Jointly, the core elements aim to
predict whether a woman will adhere to a healthy lifestyle to decrease her overall risk for
chronic disease.
Perceived threat refers to the belief that one is at risk for a specific health threat,
while perceived susceptibility addresses that individual’s risk perception. Perception
varies greatly among people. A person’s perceived benefits are influential in the adoption
and continuance of the overall behavior change (Janz & Becker, 1984). Individual beliefs
regarding the overall impact of a particular change differ. The perceived barriers to a
positive behavior change/action can impede initiation and/or adherence to a particular
program (Janz & Becker, 1984). Cues to action are events that initiate action. Selfefficacy is the belief that one can follow-through with the action (Strecher & Rosenstock,
1997).
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The theoretical foundation for which this research project is based upon is the
socioecological model. According to the socioecological model, individual behavior can
be influenced at multiple levels: individual, interpersonal, organizational, community,
and public policy (Institute of Medicine, 2003). The model combines individual behavior
with social and physical environments, while recognizing the level of self-responsibility
that individuals have to take for positive lifestyle change and the outside forces that
influence individual behavior. The socioecological model acknowledges the interwoven
relationship between the individual and their environment. Behavior is influenced largely
by individual, intrapersonal, organizational, community, and public policy. Barriers to
healthy behaviors are common within the community as a whole; however, as barriers are
addressed or removed, behavior change among the women is achievable and sustainable.
The physical and social environments in which people live play a large role in
influencing individual behavior.
The socioecological model focuses upon the larger universe of influences on
human behavior. It offers strategies for potential behavior changes at various levels. This
model explains how lifestyle choices are individual choices made in the midst of the
various environments in which the individual is nested (Institute of Medicine, 2003). The
WISEWOMAN program targets the individual and intrapersonal levels by focusing on
what motivates the woman, while the interpersonal level is addressed in that the
WISEWOMAN program provides social support for the woman. Addressing these levels
is an essential program component, as they provide the fundamental support necessary
for behavior change to occur. Figure one illustrates the logic model for the
WISEWOMAN program.
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Figure 1. South Dakota WISEWOMAN logic model (South Dakota Department of
Health, 2008).
An outcome evaluation is defined by the CDC (1999) as a “systematic collection
of information to assess the impact of a program, present conclusions about the merit or
worth of a program, and make recommendations about future program direction or
development” (p. 2). Evaluation information is an essential part of evidence-based
decision-making and the evaluator is most effective by focusing the evaluation based
upon the needs of managers, policymakers, administrators, and practitioners (Fitzpatrick,
Sanders, & Worthen, 2004). The framework for the South Dakota WISEWOMAN
outcome evaluation will compare the change in blood pressure, blood glucose, total
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cholesterol, and BMI between women attending screening sessions and lifestyle
intervention sessions and women attending only clinical screening and rescreening at 10
to14 months. This evaluation will assist project leaders by providing data to help improve
the efficacy, reach, and cost-effectiveness of WISEWOMAN.
WISEWOMAN Study Procedures
The process used to screen participants for heart disease and stroke risk factors
through South Dakota’s WISEWOMAN program mirrors the national procedures. It is
comprised of four steps. First, participants complete the program enrollment form.
Completion of the form enrolls participants in both the BCCEDP and WISEWOMAN
components of AWC! The form includes a brief description of the programs, a consent
for release of information, personal data (e.g., name, demographic information, screening
history, and medical treatment history), and eligibility determination questions (to be
completed by the provider staff member verifying the woman’s eligibility for BCCEDP).
When a participant’s eligibility for the program has been verified by a provider-site staff
member, the participant moves into the office visit phase of the screening process. This
phase includes blood pressure measurements, blood draws and weight and height
measurements.
Next, the participant completes the AWC! assessment form. This form requests
information about the participant’s personal health history. Information requested
includes previous diagnoses of high cholesterol, high blood pressure, or diabetes;
smoking history; history of medically-recommended inactivity; exercise and stretching
habits; fruit and vegetable consumption; and weight history. The form also asks
participants to indicate which learning style suits them best (in-person counseling,
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telephone counseling, or self-study). Program staff uses this information to plan
interventions for each participant.
Participants move into the office visit phase of the screening process where blood
pressure measurements, blood draws, and weight and height measurements are taken. Lab
Summary Forms and Visit Summary Forms are the standard reporting forms for the
Program. The Lab Summary Form is used to report blood lipids; blood glucose,
quantitative or Glycated Hemoglobin (HbA1c). In some cases diagnostic tests may be
needed such as; Calcium, Comprehensive Metabolic panel, Creatinine, Microalbumin,
Potassium, Urinalysis, Oral Glucose Tolerance Test. The laboratory or screening clinic
sends the Lab Summary Form directly to the Department of Health, AWC! Program.
After the participant leaves the provider-site, provider staff complete lab work on the
blood draws, complete the enrollment form by adding screening result values, and
submits the form to the WISEWOMAN central office at the South Dakota Department of
Health Laboratory.
South Dakota’s AWC! WISEWOMAN program is unique in that all 267
screening provider sites are capable, qualified, and equipped to provide all necessary
diagnostic services. After screening is complete, providers submit participants’
enrollment forms (including screening values) to the AWC! central office. The Records
Manager ensures that data from each form are entered into the project data system
provided by external contractor MaxTrac. MaxTrac generates a referral notice for the
assigned interventionist. The system emails a notice to the interventionist, who can then
log into the secure data system from any web-connected computer and reviews all
information about the participant (including screening values).Within one week, the
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interventionist sends the participant a welcome letter and brochure about the
intervention (South Dakota WISEWOMAN, 2008).
Between a week and 10 days later, the interventionist attempts to contact the
participant by phone. The interventionist tries to contact the participant at least three
times over a period of 2 weeks before closing the referral. When the interventionist
contacts the participant by phone, they make arrangements for second and third
intervention sessions in person, by phone, or through self-study. The LSI sessions offer
women with elevated or alert screening values up to four lifestyle interventions in person,
by phone, or through self-study.
South Dakota’s lifestyle interventions are based on DiClemente and Prochaska’s
(1983) stages of change model. The interventionists differentiate and personalize
intervention services offered to participating women based on the individual factors
including risk factors, behavioral goals and willingness to change. Each factor is
described in more detail below.
Risk Level
The AWC! program staff divide women into three categories based on their level
of risk. Low risk women are those that have screening values (BMI, blood pressure, and
all labs) within normal ranges for all indicators. Moderate risk women have at least one
screening value in the elevated range. High risk women have at least one value in the
alert range (South Dakota WISEWOMAN, 2008). Based upon risk level the woman
receives either minimal or enhanced intervention sessions (South Dakota
WISEWOMAN, 2008). The minimal intervention involves screening, referral and on-site
counseling (South Dakota WISEWOMAN, 2008). The enhanced intervention sessions
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include screening, referral, and extended on-site counseling, plus skill building and
facilitation of programs to improve diet and physical activity (South Dakota
WISEWOMAN, 2008).
Behavioral Goals
Interventionists assess women’s conceptual understanding of behavioral goals
during verbal risk reduction counseling and intervention sessions. Interventionists also
assist women who have never or only infrequently set behavioral goals related to healthy
behaviors learn how to choose goals that are reasonable and well-defined. Women who
already understand how to set clear and attainable health goals for themselves are assisted
with deciding what their short- and mid-range goals should be (South Dakota
WISEWOMAN, 2008).
Willingness to Change
AWC! assesses women’s readiness to change in two ways. During the first
intervention session, participants are asked to indicate their level of interest in taking part
in free nutrition and physical activity education. The participant’s response to this
question gives the interventionists a preliminary indicator of her readiness to accept the
idea that her health condition might call for lifestyle changes. Interventionists are trained
to measure women’s readiness to change during their initial telephone call using a
motivational interviewing algorithm (South Dakota WISEWOMAN, 2008).
Based on participants’ initial motivational interview, interventionists indicate
which stage best describes each participant. Information about a woman’s risk-level,
behavioral goals, and readiness to change determines the intensity and emphasis of the
woman’s intervention program and the strategies used to work through her objections and
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concerns about lifestyle changes. For example, women at the contemplation stage are
encouraged to examine the pros and cons of adopting healthy lifestyle habits whereas
interventionists help women at the action stage develop self-efficacy for dealing with
obstacles.
The South Dakota Department of Health uses the evidence-informed, culturally
appropriate curriculum called A New Leaf: Choices for Healthy Living (New Leaf). This
curriculum forms the core of every woman’s AWC! lifestyle intervention program,
regardless of the format in which she chooses to participate in intervention sessions. New
Leaf comprises sections on ten topics: (a) food assessment and tips, (b) healthy eating, (c)
physical activity assessment and tips, (d) keeping active, (e) weight assessment and tips,
(f) a healthy weight, (g) diabetes prevention and management, (h) bone health assessment
and tips, (i) smoking and quitting assessment and tips, and (j) stress and depression. The
manual’s authors wrote to a sixth-grade reading level so as not to overwhelm participants
with limited literacy. Colorful graphics are used to organize the manual and call attention
to summary material. Participants can choose to participate in interventions in person,
over the phone, or via self-study. Participating women complete rescreening between 10
and 14 months after baseline screening.
Participants in South Dakota’s AWC! WISEWOMAN program also have access
to resources that support healthy lifestyles and behaviors through a statewide network of
community coalitions. Each coalition receives funding from a statewide Federal Physical
Activity and Nutrition grant from the CDC, to bring together healthy living resources in
their communities. Most of the 267 AWC! provider sites are close to at least one healthy
living coalition (South Dakota WISEWOMAN, 2008). The AWC! interventionists refer
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participants they are assigned to serve to their local coalition for help accessing local
resources (South Dakota WISEWOMAN, 2008). In addition, the Department of Health’s
Office of Community Health Services maintains an office in 63 of South Dakota’s 66
counties (South Dakota WISEWOMAN, 2008). Each office maintains a registry of
community healthy lifestyle resources in their county that WISEWOMAN participants
can access (South Dakota WISEWOMAN, 2008). For example, the Department of Health
(2007) forged a partnership with the South Dakota Department of Game, Fish, and Parks
and all WISEWOMAN participants receive a pass enabling them to access every South
Dakota state park free of charge. The Department of Health offers a wide array of healthy
lifestyle resources to program participants online and over the telephone free of charge.
Review of Empirical Studies
A literature review, beginning with publications in 2001, was conducted using the
following search engines: EBSCO, ProQuest, Ingenta, Medline Plus, PubMed, and
Highwire Press. Using the keyword WISEWOMAN alone and in combination with
intervention, lifestyle intervention, behavioral intervention, chronic disease screening,
cardiovascular disease, South Dakota, and woman/women. Other terms, including blood
pressure and cholesterol screening, in combination with women and the United States
also were used.
Low-income populations are at-risk for chronic disease (Liao et al., 2004).
Healthy behaviors are influenced by environment (Haber & Looney, 2003). Although
intervention programs targeting low-income, lower socioeconomic neighborhoods and
environments are rare, there are some community-based intervention programs targeted
at disparate populations. Jilcott, Laraia, Evenson, Lowenstein, and Ammerman (2007)
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synthesized WISEWOMAN research projects and current community-based
intervention tools into one document. Both qualitative and quantitative research was
included. A pilot study with women residing in the community was also conducted to
assess the overall effectiveness of the materials provided in the intervention. The
researchers concluded that barriers to healthy behaviors included access to fast food,
crime, high cost of fitness centers, lack of child care, and lack of information about
physical activity. Jillcott and her colleagues suggested that the WISEWOMAN program
is capable of tailoring the intervention to address women’s unique barriers to healthy
behaviors within the community served.
Will et al. (2004) identified barriers to intervention sessions such as provider
skepticism, social isolation, unsafe neighborhoods, and access to healthy foods. The
WISEWOMAN program is currently revamping the structure of the intervention sessions
and adopting the socioecological model into intervention planning.
Functioning of WISEWOMAN Programs
The WISEWOMAN program is being implemented in three phases. Phase one
(1995-1998) focused on research, in phase two (1999-2007) funding was divided into two
categories: research funding or standard projects funding. Implementation of phase three
has just begun for fiscal year 2009. Will and Loo (2008) summarized the lessons learned
and the challenges to be addressed in phase three. In phase one, the WISEWOMAN
conducted randomized controlled trials, nonrandomized control trials, and quasiexperimental (pre/posttest), cross-sectional studies, case studies, as well as conducted
interviews to obtain qualitative data. Using those collected data, phase two set
performance indicators for the nonresearch WISEWOMAN sites. In phase three, Will

24
and Loo identified key challenges and recommendations. Some of the challenges
identified were maximizing program reach in order to tailor the program resources to
participants’ needs, targeting at-risk/disparate populations using vital statistics and
hospital discharge data, and providing theory driven behavioral counseling and
interventions, increasing rescreening rates, and increasing community partnerships and
collaborations. The program recommendations were focused primarily on clarifying and
defining the vision of the WISEWOMAN program and increasing program reach and
effectiveness. By addressing these challenges, it is hoped that the WISEWOMAN will be
able to serve more women and provide more screenings, which will in-turn, reduce
cardiovascular disease in the target population.
Sanders et al. (2001) conducted a needs assessment to identify training needs of
WISEWOMAN project staff in relation to nutrition counseling and education
development and implementation. WISEWOMAN staff received training that addressed
the gaps identified in the needs assessment. At the 6-month follow-up, a majority of the
participants indicated that the course increased their knowledge and skills in program
planning. Using the evaluation of the course, the CDC WISEWOMAN team intends to
further assess program training on topics addressed in the behavior counseling and
education.
Mays et al. (2004) conducted a formative assessment of perceived opportunities,
challenges, and strategies associated with integrating WISEWOMAN into community
health center settings. In 2002, a panel of 21 stakeholders provided qualitative input to
assist in the improvement of the WISEWOMAN capacity to reduce the burden of
cardiovascular disease among WISEWOMAN participants. They found that the
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stakeholders have issues with the integration of the WISEWOMAN program in
community health centers. Barriers such as competing demands on health center
resources, difficulties hiring new staff for new programs, and administrative burdens
associated with data collection and reporting were identified.
The Community Change Chronicles was drafted by staff at the North Carolina
Department of Health and Human Services (2009) to highlight policy change and the
promotion of cardiovascular health. Lewis, Johnson, Farris, and Will (2004) set forth to
explore the methods used in North Carolina’s WISEWOMAN program and conducted an
exhaustive review of literature to evaluate program strengths and weaknesses and
promote research-based interventions. Their conclusions are summarized below.
The North Carolina WISEWOMAN program assessed the project staff attitudes,
beliefs, and barriers to successful implementation of the program. Jilcott et al. (2004)
conducted a cross-sectional baseline and one year follow-up of program staff to find out
more information in regards to their beliefs about WISEWOMAN participants’
motivation, diet, and physical activity behaviors. The results indicated that staff felt that a
majority of the WISEWOMAN participants were not motivated to change their current
lifestyle in regards to dietary change and physical activity. The staff felt that they had
adequate resources to assist in behavior change. The staff also felt that time, access to
low-cost medication, lack of attendance at follow-up sessions, and program
implementation in clinic sites were challenges in sustaining the WISEWOMAN program.
In order to assess the maintenance of health behavior, 22 North Carolina
WISEWOMAN sites, consisting of 511 participants, were randomly assigned to a
computer-based post 12 month health messaging intervention or control group. Data were
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obtained using telephone administered surveys, which introduces bias into the study
because of self-report. Jacobs et al. (2004) found that the enhanced intervention
participants were more likely to adhere to a healthy diet than the control group.
A quantitative and qualitative evaluation of the Iowa WISEWOMAN program
was conducted by Gatewood and colleagues in 2008 to identify barriers to physical
activity and nutrition. Participant’s self-efficacy in relation to program participation was
also examined in order to identify variables predictive of program participation. The
random sample consisted of 339 WISEWOMAN participants in Iowa between March
2003 and January 2006. The sample was representative of women who attended six or
more interventions; women attending only one intervention session; and women who did
not attend any intervention sessions. A paper survey assessed barriers to intervention
attendance, barriers to health behavior change, food security, and self-efficacy for
nutrition and physical activity. The results of the survey indicated that women that did
not attend intervention sessions or women who attended only one session were more
likely to report perceived barriers to intervention attendance than those who attended at
least six intervention sessions. Although this study had a small sample size, the results are
helpful for health promotion planning. The authors concluded that interventions needed
to fit better into the women’s lives. The time, place, location were not sensitive to the
program participants lifestyle. The intervention content also needs to address the
participant’s perceived risk (Gatewood et al., 2008).
Viadro, Farris, and Will (2004) conducted a review of case studies from three
WISEWOMAN sites (Arizona, North Carolina, and Massachusetts) to assess phase one
project design and implementation. Data were obtained from document review and
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telephone interviews with project directors, coordinators, researchers, and a CDC
project officer. Using those data, Viadro et al. identified themes across the project sites.
The themes identified that a strong, research-based intervention and screening evaluation
needed to be implemented, research and program services needed to be combined, and
NBCCEDP and WISEWOMAN needed to be better integrated. All three project sites
were deemed successful in serving at-risk women and strengthening partnerships to
develop a comprehensive women’s health model and develop linkages in the community
to better serve and support the needs of the WISEWOMAN participants.
Review of the Lifestyle Interventions
The WISEWOMAN program provides chronic disease screenings and lifestyle
interventions for disparate women aged 40 to 64 in the United States. In South Dakota,
women aged 30 to 64 are eligible because of the small population base in the state (South
Dakota WISEWOMAN, 2008). In the initial phase of the program, North Carolina,
Massachusetts, and Arizona were awarded funding to conduct enhanced projects (CDC
WISEWOMAN, 2003). These sites had both intervention and control groups (CDC
WISEWOMAN, 2003). In phase two of the WISEWOMAN program, funding was
awarded for standard projects (CDC WISEWOMAN, 2003).The standard projects did not
have control groups (CDC WISEWOMAN, 2003). The aim of the standard projects was
to assess the cost/benefit of the program. In 2004, Will, Farris, Sanders, Stockmyer, and
Finkelstein conducted a study to assess the overall feasibility and effectiveness of the 12
WISEWOMAN project sites. Data were collected for 8164 participants in 2002. The
outcome measures used were blood pressure, lipid levels, and tobacco use. Intermediate
measures include self-reported diet and physical activity, measures of readiness for
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change, and barriers to behavior change. The screening provided by the program
resulted in 24% of women being newly diagnosed as having high blood pressure (24%)
and high cholesterol (48%). Among the participants, 75% were obese, while 42%
reported themselves as current smokers. Screening sessions clearly had an impact;
however, the overall effectiveness of the intervention sessions was not as clear. This
study illustrated that the WISEWOMAN program is reaching the target audience that are
at risk for chronic disease.
WISEWOMAN participants have high BMI and there is a high prevalence of
smoking among participants (Mobley, Finkelstein, Khavjou, & Will, 2004). The
WISEWOMAN program offers lifestyle intervention sessions to improve participants’
overall health and help the women quit smoking. Between January 2001 and December
2002, Mobley et al. conducted an analysis of WISEWOMAN participants from
Connecticut, Michigan, Nebraska, North Carolina, and South Dakota to examine BMI
and smoking behavior in conjunction to neighborhood socioeconomic characteristics.
Using zip codes, the authors concluded that there is a link between economically
disadvantaged neighborhood and rates of smoking and obesity (p< 0.05). Although this
study revealed spatial clustering in regards to cardiovascular risk factors, it is not
inclusive of all WISEWOMAN sites, nor did the authors indicate the total number of
participants in this particular study. There was also potential bias in that smoking rates
were self-reported. This study provided the WISEWOMAN program with useful
information to address chronic disease risk factor disparities in economically challenged
communities across South Dakota.
WISEWOMAN participants with abnormal or alert lab values are able to obtain
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medication to control blood pressure, cholesterol, and diabetes at free and reduced
cost. In 2007, Khavjou, Finkelstein, and Will studied the impact of the medication access
on coronary heart disease risk factors among 2385 WISEWOMAN participants in eight
states. A pre-post analysis was used to estimate risk factor changes by medication status
at 12 months. The participants who received medication had significant improvements in
overall blood pressure and total cholesterol levels. The authors concluded that there was a
reduction in coronary heart disease risk factors using the screening and lifestyle
intervention sessions.
Will, Khavjou, Finkelstein, Loo, and Gregory-Mercado (2007) conducted a study
to quantify the overall benefit of medicinal use on glucose, cholesterol, and ten year
coronary heart disease risk among 29,387 WISEWOMAN participants from 1998 to
2005. Ten year coronary heart disease risk estimates a 10-year probability of developing
a coronary heart disease. It is assessed using a formula developed by Anderson (1991)
that uses sex, age, systolic blood pressure, total cholesterol, high-density lipoprotein
cholesterol, smoking, and diabetes status as input risk factors to help explain the change
in 10-year CHD risk. Will et al. (2007) used baseline and follow-up data for prediabetic
(n= 688) or diabetic (n= 338) participants, the researchers employed a multilevel
regression model. They found that that 2.9% of prediabetic participants experienced
statistically significant improvements in their glucose, 2.1% improvement in cholesterol
level, and 4.3% improvement in ten year coronary heart disease risk; 11.5% of newly
diagnosed diabetics had statistically significant improvements in their glucose level, 3.1%
to 3.5% had improvement in their blood pressure, and 6.4% of their total cholesterol
levels improved. Among those with previously diagnosed diabetes, 1.9% to 3.4% had
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significant improvement in their blood pressure, 3.8% had improvement in total
cholesterol, and 8.5% had improvement in ten year coronary heart disease risk (p < .05).
The researchers concluded that comprehensive, patient driven interventions will
effectively produce the same results as presented in the WISEWOMAN program, if
replicated on a much broader scale.
The WISEWOMAN program addresses racial/ethnic disparities in cardiovascular
disease. Finkelstein, Khavjou, Mobley, Haney, and Will (2004) assessed BMI, blood
pressure, total cholesterol, diabetes, and smoking prevalence in relation to their 10 year
cardiovascular disease risk. High total cholesterol, hypertension, and diabetes awareness
and access to treatment were also examined. Baseline and rescreen data were collected,
representing 5596 WISEWOMAN participants from January 2001 to December 2002.
Using regression analysis, the results indicated a racial/ethnic disparity among the
WISEWOMAN participants. African Americans were the most at-risk population with
more obesity, higher blood pressure and diabetes rates, and a higher 10 year coronary
heart disease risk (p < 0.05).
In 2008 Feresu, Zhang, Puumala, Ullrich, and Anderson examined the Nebraska
WISEWOMAN program to assess cardiovascular risk factors and changes in the 10-year
coronary heart disease risk. Data were collected on 10,739 Nebraska WISEWOMAN
participants’ women between 2002 and 2004. Screening and rescreening results on age,
race, education, residence, smoking status, disease history, medications and medical
screening results for BMI, blood pressure, total cholesterol, and blood glucose were
obtained. Feresu and colleagues found that age was the most significant factor in
determining cardiovascular risk. Women aged 60 to 64 had a higher risk for high blood
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glucose, blood pressure, and overweight/obesity. Women aged 50 to 59 and 60 to 64
had higher rates of high blood pressure. The authors concluded that race, age, and
residence were related to cardiovascular disease risk. This study highlights the
effectiveness of screening in decreasing the burden of cardiovascular disease.
The Massachusetts WISEWOMAN program conducted a randomized control
study to assess the overall effectiveness of the WISEWOMAN program at reducing
cardiovascular disease risk factors. Baseline data were collected between March and June
1996 on blood pressure, total cholesterol, fruit/vegetable consumption, and exercise
levels for 1443 women. The women were assigned to minimum intervention or enhanced
intervention. Women in the minimum intervention received lifestyle interventions
focused primarily on nutrition and physical activity to reduce risk of cardiovascular
disease. The enhanced interventions included the latter, plus one on one nutritional and
physical activity assessments and counseling, individual and group education, and
behavioral intervention activities. Mixed model logistic regression analyses were
conducted to test the overall effectiveness comparing change in the outcome variables
over time, odds-ratios were not reported. The analysis results indicated that in both
groups blood pressure decreased significantly; total cholesterol did not change
significantly in either group; in both groups, fruit/vegetable intake increased. Women in
the enhanced intervention group also had a statistically significant increase in physical
activity. The study results indicated that cardiovascular disease screening and
interventions are effective at reducing risk factors for cardiovascular disease.
In an effort to assess the prevalence of obesity in low income African American
and White women in North Carolina, Nelson et al. (2002) examined co-occurring risk
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factors associated with coronary heart disease. There were 1284 White women and 754
African American women included in the study. Among White women, 69% were
overweight or obese and 87% of African American women were overweight or obese.
Age, BMI, total cholesterol, self-reported diabetes, smoking, and 10 year coronary heart
disease risk were analyzed using means and frequencies. Overall, obese (17.7%) and
nonobese (13.3%) African-American women had three or more co-occurring risk factors
for cardiovascular disease. Among White women, obese (26.9%) women had more cooccurring risk factors than nonobese women (13%). This study is indicative of higher
prevalence of co-occurring health risk factors for cardiovascular disease among AfricanAmerican women (p < .05). The authors concluded that more longitudinal studies are
needed to solidify the effect of obesity on cardiovascular disease risk among AfricanAmerican and White women.
The North Carolina WISEWOMAN program conducted a nonrandomized study
to assess the overall effectiveness of the WISEWOMAN program in reducing
cardiovascular disease risk factors. There were 31 local health departments in North
Carolina selected, with 17 clinic sites conducting the minimum intervention and 14
clinics conducting the enhanced interventions. Baseline data were collected on blood
pressure, total cholesterol, fruit/vegetable consumption, and exercise level for 2148
women. The women were assigned to minimum intervention or enhanced intervention.
Women in the minimum intervention received lifestyle interventions focused primarily
on nutrition and physical activity to reduce risk of cardiovascular disease. The enhanced
interventions included the latter, plus three one-on-one nutritional and physical activity
assessments and counseling, individual and group education, and behavioral intervention
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activities. The results indicated that among the 2148 women screened, 40% had high
total cholesterol, 63% had high blood pressure, and 76% were overweight or obese.
Among the two groups, at the six month follow-up, change scores were calculated and
the results revealed positive changes in total cholesterol, blood pressure, and BMI in both
the enhanced intervention group and minimal intervention group (p < .05). There were no
significant differences between the two groups and the results were not statistically
different from the minimal intervention group. This suggests that any level of
intervention is effective at reducing cardiovascular disease risk factors.
Identifying Best WISEWOMAN Practices
Parra-Medina, Wilcox, Thompson-Robinson, Sargent, and Will (2004) reviewed
22 high-quality WISEWOMAN physical activity educational materials targeted at
African-American WISEWOMAN participants. There were two expert panels and eight
focus groups that evaluated the visual appeal and content of the educational materials
used among the WISEWOMAN providers. Data were both quantitative and qualitative. It
was concluded that the most appealing educational materials were those that were brief,
colorful, simple, and applicable to the woman and her family. The authors recommended
that the process could be replicated by other programs; however, the study’s primary
limitations were that the women were all from the Southeast part of the United States and
African-American.
Farris, Will, Khavjou, and Finkelstein (2007) used Glasgow’s (2006) REAIM
(reach, effectiveness, adoption, implementation, and maintenance) framework to assess
the impact of 14 WISEWOMAN sites in North Carolina from 2001to 2003. Reach,
efficacy/effectiveness, adoption, implementation, and maintenance identified high
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performing and low performing sites. High performing sites have an extensive referral
network, incentives, and lifestyle intervention protocols in place, on-going staff training,
and evaluated yearly screening results of participants, while low performing sites do not.
There were five high performing sites. The WISEWOMAN data collected helped assess
cost-benefit and cost-effectiveness and provided appropriate outcome measurements to
better define the impact of the WISEWOMAN program on reducing the burden of
cardiovascular disease among women.
Besculides et al. (2006) used the REAIM framework to explore best practices
used by WISEWOMAN program to implement lifestyle intervention sessions that target
risk factors for cardiovascular disease. There were five WISEWOMAN sites selected
from 15 total sites. The five sites were selected based on project longevity and the
availability of quantitative rescreening data for at least 100 women at 10 to14 months.
Blood pressure, total cholesterol, BMI, and smoking status were assessed using a mixedmethod approach. Theme tables were drafted by researchers to identify best practices. An
algorithm was applied to each theme to assess how frequently it was used across the five
sites. There were 87 best practices identified. Of the best practices, 13 were used by high
performing sites. High performing sites had an extensive referral network, incentives, and
lifestyle intervention protocols in place, on-going staff training, and evaluated yearly
screening results of participants. The identification of these best practices will assist in
program implementation to identify successful factors for WISEWOMAN programs.
Besculides et al. (2006) used the REAIM model and in-depth case studies to
identify best practices for WISEWOMAN Programs. Five WISEWOMEN projects were
included in the study and qualitative data was collected from each. More specifically,
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semi-structured interviews were conducted with key informants and staff, while focus
groups and observations were conducted with program participants. The overall goal of
the study was to learn more about the best practices used to implement the program and
the impact of the program on participants. All data was subject to thematic analysis and a
standardized algorithm was used to identify how often certain practices were used by the
program sites. Practices used most often by high-performing sites were considered best.
Besculides et al. (2008) conducted a study to describe the best practices for
implementing lifestyle intervention sessions used in the WISEWOMAN program. Using
a mixed-method approach, Besculides et al. used the RE-AIM framework for
WISEWOMAN site selection to classify and analyze qualitative data. Five project sites
were selected. In order to classify best practices, an algorithm was designed that specified
when only high performing sites used a practice; it was then considered best. When low
performing sites used a practice, it was not considered best. If both low and high
performing sites used a practice, a case study was conducted to explain the
implementation method used. A total of 87 best practices were identified. A subset of 31
best practices were used by high and low performing sites. These practices were further
studied to identify the barriers to success among the low performing sites using the same
practice as the high performing sites. The overall effectiveness was found to lie in staff
training, use of incentives, having an implementation and evaluation plan, and the ability
to adapt the plan as needed. This study identifies some of the key components in
successful WISEWOMAN interventions. Using these data, other public health agencies
can implement successful programs in their public health delivery.
The WISEWOMAN program uses an integrated healthcare approach to deliver
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lifestyle interventions. Goldstein, Whitlock, and Depue (2004) gathered evidence to
assess the overall evidence related to the efficacy of intervention programs addressing
physical activity, diet, obesity, cigarette smoking, and alcohol use/abuse. This was done
using the United States Preventive Services Task Force (USPSTF), the United States
Public Health Service (PHS), and conducting a literature review. The authors found that
the most efficacious interventions were in the areas of physical activity, diet, smoking,
and risky alcohol use. They recommended that interventions should have systems
support, consist of a multidisciplinary team of trained staff, make referrals for patients
needing more intensive treatment, and use a collaborative community approach.
Intervention programs utilizing the 5 A’s approach of assess, advise, agree, assist, and
arrange, have the most influence on lifestyle.
Lewis et al. (2004) set forth to find out more about the methods used in North
Carolina’s WISEWOMAN program and conducted an exhaustive review of literature to
identify other methods of successful programs in order to identify project success stories
from all the funded WISEWOMAN sites. The Alaska WISEWOMAN project was
highlighted. There were 10 strategies used by the WISEWOMAN program in drafting a
success story report. The 10 strategies included: identifying the target audience, develop a
systematic process, develop a standardized form, collect success stories, conduct
interviews, develop appealing format, write and revise stories, organize stories, design
and print publication, and disseminate publication. WISEWOMAN Works was published
in March 2003. The publication was used to educate staff about the WISEWOMAN
program, shares lesson learned, raise program awareness, and identify challenges and
opportunities. The success stories provide a venue for health promotion programs to
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document success and evaluate program strengths/weaknesses and promote researchbased interventions.
Cost Effectiveness
The WISEWOMAN Workgroup, consisting of program directors, CDC project
officers, and program staff, conducted an evaluation of the Massachusetts, Arizona, and
North Carolina WISEWOMAN program. Data were obtained using the baseline
screening, 6 months, and 12 months measures of blood pressure, total cholesterol, BMI,
and physical activity from 4842 WISEWOMAN participants. The projects were divided
into either enhanced intervention or minimum intervention groups. Risk factors for
cardiovascular disease are common in all three states. Women in North Carolina (40%)
and Massachusetts (40%) were more likely to have high total cholesterol; high blood
pressure was more common among women in North Carolina (63%); women in Arizona
were more likely to be overweight (83%). The authors concluded that more research
needs to be conducted on cost-effectiveness in order to assess the long term effect on the
reduction of risk factors using enhanced intervention method.
In 2004, Finkelstein et al. conducted an assessment of the overall costeffectiveness of the WISEWOMAN program. Between June 2000 and December 2003,
data were obtained using 3015 baseline and rescreening results at one year. Data
collected included height, BMI, blood pressure, total cholesterol, and blood glucose
levels. Program cost data were collected from the nine project sites for a 6 month period.
Program cost included labor, outreach, screening, interventions, and materials. The
average cost of providing WISEWOMAN activities was $270 per participant.
WISEWOMAN participants significantly improved their ten year coronary heart disease
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risk, including cholesterol and blood pressure. Smoking rates also decreased. All the
improvements resulted in a $470 cost-effectiveness ratio for every percentage point
reduction in coronary heart disease risk (p < .05). The authors concluded that the
WISEWOMAN program is cost-effective and for every life year gained, there was $4400
saved in direct and indirect costs. The analysis was limited in that the sensitivity analysis
is subject to interpretation based on many different variables. There was also no control
group involved in the analysis.
Finkelstein, Troped, Will, and Palombo (2006) conducted an evaluation of the
cost-effectiveness of the Alaska WISEWOMAN project. They found that the average
cost of the intervention was $487 per women for a minimum intervention and $603 for an
enhanced lifestyle intervention. It was estimated that for a full year of life gained, it save
$5000 in direct and indirect costs.
Hagberg and Lindholm (2006) conducted a literature review to assess the costeffectiveness of healthcare-based interventions aimed at improving physical activity. A
total of 26 articles were found. The following variables were used to categorize the
physical activity intervention programs: primary intervention method, study design, costeffectiveness ratios, and authors’ conclusion regarding cost-effectiveness. Exercise
efficacy, population penetration, and adherence to physical activity were analyzed to
assess the overall treatment effect. The prevention effect was measured using decrease in
risk of future poor health. The overall health effect assessed the quality life years. The
authors concluded that there are many cost-effective interventions targeted at high risk
groups, such as the elderly and those with coronary heart disease. There is insufficient
research regarding the cost-effectiveness of prevention-based interventions targeting
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sedentary people.
Other WISEWOMAN Programs
In 1999, the South-central Foundation in Alaska was awarded WISEWOMAN
funding. Alaska has designed and implemented a program specific to Alaska native
women, called Traditions of the Heart. Stefanich et al. (2005) summarized the
development, adaptation, and implementation of this program. Extensive formative data
collection was conducted to ensure that the interventions met the needs of the Alaska
Native women. Diet, physical activity, topics of interest, barriers, and preferred learning
venue were collected via survey of 43 Alaska Native women aged 40 to 64. It was
concluded that small group settings and programs that were sensitive to Alaska Native
culture were best.
Stfanich et al. (2005) also conducted a 12-week randomized pilot study, using 44
women, to test the effectiveness of the intervention content, materials, and format. The
women were assigned to the intervention or control group and a pre and posttests were
used to assess behavior change. Following the pilot study, an overall program evaluation
was conducted to determine whether the interventions were effective and relevant.
Eighty- three percent of the participants felt that the intervention length, materials, and
individual counseling sessions were effective. The information from the evaluation was
used to make programmatic changes before broader scale implementation. The
assessment tools were simplified and information regarding heart attack and stroke
awareness were added to the curriculum. There were six overall themes identified by the
authors as recommendations to other programs wanting to design intervention programs
for specific populations. Those themes included: adapt current, research-based programs
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to meet the needs of the target population; gather input from the target population and
professionals serving the target population in the initial program planning; incorporate
qualitative research into evaluation; use incentives; have a diverse strategic planning
committee, and; use culturally appropriate materials.
In a follow-up pilot study, the Alaska WISEWOMAN program conducted a pilot
randomized control trial to assess feasibility and cultural acceptability, as well as to
develop enrollment procedures. Four clinical sites were selected and data were collected
between October 2000 and April 2001. Initial screening data (blood glucose, blood
pressure, total cholesterol, and height/weight) were obtained to determine overall impact.
There were a total of 76 women enrolled in the program. Of the 76 participants, 44 were
randomized to the intervention group. Mean individual changes were assessed at 12
weeks and women reported more physical activity and higher confidence in their ability
to achieve regular physical activity. The results of the pilot study assisted in
programmatic changes to better fit the Alaska Native population. The results of the pilot
study suggest building on the strengths of the community and assist in refining
population specific intervention programs.
The Massachusetts WISEWOMAN program was one of three project sites
initially funded by the CDC. In 1996, Finkelstein et al. conducted an evaluation of the
cost-effectiveness of the WISEWOMAN project. A group randomized control study
design was used to collect data from 11 WISEWOMAN sites over a one year period.
Women were assigned to either an enhanced lifestyle intervention or minimum
intervention. The effectiveness of the program was assessed using blood pressure, blood
glucose, total cholesterol, BMI, age, and smoking status to assess the overall 10 year
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coronary heart disease risk. The women in the minimal intervention group had a 9.4%
CHD risk. The women in the enhanced lifestyle interventions group had 9.8% CHD risk.
After one year, both groups had a slight decline in CHD risk (0.5 vs. 0.2). The authors
concluded that the results were not statistically significant; however, the Massachusetts
WISEWOMAN program made changes to program delivery. The WISEWOMAN
program streamlined intervention delivery and standardized protocol in effort to
minimize program implementation differences among projects.
Feresu, Zhang, Puumala, Ullrich, and Anderson (2008) conducted a study to
assess the overall 10 year CHD risk among Nebraska women enrolled in the
WISEWOMAN program. Sociodemographic factors were examined in order to assess the
relationship to CHD risk factors such as blood pressure, cholesterol, BMI, and diabetes.
Between September 2002 and December 2004, a total of 10, 739 WISEWOMAN
participant screening values were reviewed. Seventy-four percent of the women were
located in rural areas; 54% were between the ages of 40 to 49; 83% were White; and 26%
reported that they were current smokers. Sixty-six percent of the women had a previous
diagnosis of high blood pressure, high total cholesterol or diabetes. The overall incidence
rate of obesity was 44 out of 1000. The incidence rate for hyperglycemia was 31 out of
1000. The overall incidence rate for hypertension was 66/1000, while there was an
incidence rate of 157 out of 1000 for high total cholesterol. Women aged 60 to 64 were
most at risk for obesity, high total cholesterol and hyperglycemia. Women aged 50 to 59
were most at risk for high blood pressure. A total of 3416 women had both baseline and
follow-up data, which indicates a barrier to follow-up sessions. Women that attended one
versus two follow-up sessions were more likely to have hyperglycemia (6.86% vs.
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4.96%) and high total cholesterol (19.99% vs. 19.47%) (p = .05). This study suggests
that sociodemographic factors increase risk of CVD among Nebraska WISEWOMAN
participants. It also indicates the need to enhance intervention reach in order to increase
follow-up sessions.
In 2004, Staten et al. conducted research on the Arizona WISEWOMAN program
using an experimental design. This study’s main purpose was to track the effectiveness of
WISEWOMAN in increasing physical activity and fruit and vegetable consumption over
a 12-month period. Three levels of intervention were used. Low intensity consisted of
provider counseling. The second level of intensity included health education classes and a
monthly newsletter, while the third level also included social support by community
health workers. The study population consisted of Hispanic women, age 50 to 64, and
data consisted of height, BMI, and blood pressure measurements. Participants were also
asked to recall their diet over the last 24 hour period. Linear regression models were used
to compare changes between the two groups, as well as interaction effects for the 217
women included in the analysis. The results indicated that overall, women in all three
intervention groups demonstrated positive change and increased the number of minutes
of moderate to vigorous physical activity over one year. Women in the most intensive
intervention group increased fruit and vegetable consumption, compared with participants
who only received the level one or level two intervention (p < .05).
Staten and colleagues (2004) demonstrated the effectiveness of lifestyle
intervention sessions in reducing cardiovascular disease risk factors; however, it lacked
statistical power to interpret significant change between the groups. Furthermore, the
sample size was very small, relative to the population served and finally, self-report diet
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recall was also subject to bias.
In a follow-up study on the Arizona WISEWOMAN project, Gregory-Mercado et
al. (2007) compared the 24-hour dietary recalls of Hispanic and nonHispanic White
women enrolled in the program. Individual nutrient intakes were compared by the
sociodemographic background characteristics thought to influence diet and predispose
them to unhealthy eating. There were 260 Hispanic women and 88 White women in the
sample. Nutrient intake including total caloric intake, total protein, total carbohydrate,
total fat, cholesterol, and total dietary fiber was assessed among the two groups.
Hispanic women had a significantly lower intake of energy intake than White
women. The comparison by the percent of calories from macronutrients indicated no
difference; however, micronutrient intake was lower for Hispanic women. Both Hispanic
and nonHispanic Whites were lacking in calcium intake. A higher intake of protein and
potassium were associated with higher BMI and vitamin E and folate intake were
associated with smoking. This study was based on self-reported dietary recall. The small
sample size is also a limitation of this study. This study provides information useful to
nutrition education programs targeting low-income, uninsured Hispanic women.
Oleson, Breheny, Pendergast, Ryan, and Litchfield (2008) conducted research on
the Iowa WISEWOMAN participants to examine the impact of travel distance to an
intervention session on overall intervention attendance. There were 787 women involved
in the randomized control trial from October 2002 to July 2005. Driving distances were
classified as rural or urban locations. An additive model suggested that distance from the
intervention site was more of an issue for women residing in a rural area than those
residing in an urban setting. Among women in an urban setting, 57.6% attended an
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intervention session, while 53.8% of woman in a rural setting attended an intervention
session. Also, women that were more educated, had health insurance, exercised less, had
higher BMI, did not smoke, enrolled earlier, and had smaller families were more likely to
attend the intervention sessions (p < .01). This study illustrates the overall impact of
distance traveled on the probability of attending the WISEWOMAN intervention
sessions. This research suggested that feasibility of participant travel to intervention
sessions is an important factor to consider when planning WISEWOMEN programs in
rural versus urban areas.
The North Carolina WISEWOMAN program has an enhanced lifestyle
intervention program that addresses behavior changes based on the chronic care model,
including environmental and individual factors in a clinical setting. In an effort to
evaluate the enhanced intervention’s effectiveness, Jilcott et al. (2006) conducted a
randomized trial from May 2003 to December 2004 to compare changes in moderate
intensity physical activity and diet at the baseline level. A total of 204 participants were
randomly assigned to control or enhanced intervention groups. Blood pressure, blood
glucose, BMI and waist circumference, and total cholesterol were also assessed. Blood
pressure was higher among the minimal intervention group than among those in the
enhanced intervention group. Both groups had participants with high BMI (75%) and
25% of the total sample were current smokers. There was no significant difference in
dietary consumption between the two groups. The enhanced and minimal intervention
groups (40%) reported neighborhood characteristics as barriers to physical activity and
healthy diet.
These initial data suggested the need for community linkages to facilitate healthy

45
behavior change. The Neighborhood Assessment and tip sheet, developed by the North
Carolina WISEWOMAN program, facilitates community development and encourages
policy change to improve community and environmental factors influencing health
related behavior. Although this study only reports initial screening results, it is useful to
other programs interested in developing a strategic plan to address environmental barriers
to physical activity and healthy diet.
Keyserling et al. (2008) conducted a randomized trial to assess the impact of
enhanced versus minimal WISEWOMAN intervention sessions on physical activity and
diet. From May 2003 to December 2004, 236 WISEWOMAN eligible women were
assigned to either enhanced intervention or minimal intervention sessions. The enhanced
interventions (EI) took place over 6 months and were comprised of two individual
counseling sessions, three group sessions, and three phone counseling sessions, followed
by a maintenance phase that consisted of one individual counseling session and seven
monthly phone counseling sessions. The minimal intervention (MI) sessions included a
one-time mailing of informational pamphlets pertaining to diet and physical activity.
Measurements were taken at 6 months and 1 year using an accelerometer to track
activity minutes, the Dietary Risk Assessment (DRA) to assess dietary intake of fruits
and vegetables, and a self- assessment of physical activity. Keyserling et al. (2008) used
descriptive statistics and outcomes were measured using ANCOVA. It was found that
there was no statistical difference in accelerometer measurements at both 6 and 12
months between the EI (M = 30.6, SE = 0.5) and MI (M = 29.9, SE = 0.4) groups; the
DRA score for side dishes (which was inclusive of fruit and vegetable intake) decreased
more at six months for the EI group (M = 7.7, SE = 0.2) than for the MI group (M = 8.8,
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SE = 0.2), which was statistically significant. However, at 12 months there was no
difference in scores among the EI (M = 8.0, SE = 0.3) and MI (M = 8.4, SE = 0.3) groups.
The self-report physical activity scores from the EI baseline (M = 29.4, SE = 0.8) to 12
months (M = 30.0, SE =0.7) increased. The opposite effect was demonstrated among the
MI group baseline (M = 29.2, SE = 0.8) and 12 month (M =28.4, SE = 0.6) scores. All
values were age adjusted. The limitations of this study include the relatively small sample
size and the self-report assessment; however, this study demonstrates the overall
effectiveness of enhanced interventions in addressing barriers to healthy behavior change.
Introduction to South Dakota WISEWOMAN
South Dakota has administered a WISEWOMAN program called All Women
Count! (AWC!) since 2000. AWC! also includes the state’s Breast and Cervical Cancer
Early Detection Program (BCCEDP). WISEWOMAN and BCCEDP are integrated in
South Dakota; the result is a comprehensive chronic disease screening and prevention
program that has served thousands of the state’s most at-risk and medically underserved
women (South Dakota WISEWOMAN, 2008). With continued funding for AWC! from
the CDC the South Dakota Department of Health has built on its successful beginnings.
The program remains committed to its three central objectives: (a) maximizing reach by
serving as many eligible women as possible statewide; (b) maximizing integration
between WISEWOMAN and BCCEDP so as to create a unified project that is as patientfriendly, provider-friendly, and cost-efficient as possible; and (c) maximizing outreach to
the state’s most underserved women (including the large American Indian population).
The AWC! program brings WISEWOMAN and BCCEDP under a single
leadership team so that the recruitment and marketing efforts of both projects
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complement one another. In this way, the marketing exposure of both projects is
maximized. Methods of recruitment include word-of-mouth from providers, family, and
friends, as well as radio, television, newspaper, Internet, posters, and booths at
community health fairs and other activities (South Dakota WISEWOMAN, 2008).
The screenings are provided at 267 provider sites; AWC! provides
WISEWOMAN-standard screening services to women across the state of South Dakota.
The great majority of screening providers are private practitioners. AWC! elected to
support such a large network of provider sites in order to overcome the barriers to
participation associated with South Dakota’s extreme rurality.
In 2005, a study on the maintenance of healthy eating and physical activity among
the WISEWOMAN participants in South Dakota was conducted. Fahrenwald (2005)
examined the maintenance of healthy eating and physical activity behaviors beyond the
six month post counseling period and examined the barriers and facilitators of healthy
behaviors. A process evaluation survey research design was used. There were 72 SD
WISEWOMAN participants included in the study that completed a 15 minute telephone
interview. Of the 72 interviews, 69 women received at least one face-to-face physical
activity or dietary counseling session.
At the first follow-up (less than 6 months from baseline screening), more than
60% of the participants in this study maintained changes in healthy eating and
improvements in healthy eating behavior were maintained by 65% of the women who
reported that they were eating a heart healthy diet. Improvements in physical activity
were maintained by 70% of the women who reported that they were regularly active at
the first follow-up period. Seven facilitators of healthy behavior were identified
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including: educational knowledge and awareness, the AWC! program, family
support, personal health conditions, family health issues, cooking healthy foods, and
feeling better. Barriers to healthy behavior maintenance included cost of healthy foods,
personal preference for less healthy foods, time, eating out, cooking for others,
availability of garden produce, and rural access to healthy choices. Four facilitators to
maintenance of regular physical activity were identified. Those included support from
others, enjoyable activity, occupational activity, and knowledge of the benefits of
physical activity. Common barriers to physical activity maintenance included access,
cost, personal health issues, time, weather and motivation.
The Women’s Prison in Pierre, SD, is one of the NBCCEDP sites where the
WISEWOMAN program trained prison staff to provide heart disease risk factor
screenings and lifestyle interventions to incarcerated women beginning in 2004. The
prison setting offers an opportunity to initiate a heart disease risk factor screening and
intervention program in an environment conducive to high levels of participation, but low
level of control in relation to physical activity and nutrition.
In 2005, Khavjou et al. (2007) conducted an analysis to assess the baseline heart
disease risk profile of WISEWOMAN participants screened in the SD state prison and
compared it with that of the general WISEWOMAN population of low-income,
uninsured women in SD. Baseline prevalence of heart disease risk factors (hypertension,
high cholesterol, smoking, and obesity) were assessed among incarcerated women in SD
relative to the general WISEWOMAN population in SD from January 2004 to 2005.
There were a total of 261 women in the SD state prison and 1,427 nonincarcerated
women. The WISEWOMAN program also collected detailed information on each
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lifestyle intervention session attended by the participants (intervention date,
intervention setting, and contact type). The results indicated that there were a
significantly higher percentage of incarcerated women (84.6%) than nonincarcerated
women (53.6%) with high total cholesterol who were unaware of their condition.
Incarcerated SD WISEWOMAN participants attended an average of two lifestyle
intervention sessions, whereas nonincarcerated women attended an average of 0.4
sessions. Intervention take-up rates were 53.3% among incarcerated women and 22.6%
among nonincarcerated women. Intervention completion rates were 42.5% among
incarcerated women and 3.6% among nonincarcerated women (p < .01).
The results of this analysis illustrate a need to implement heart disease screening
and education programs, such as WISEWOMAN, in prisons. Specifically, screenings
help to identify cases of abnormal blood pressure and total cholesterol that otherwise
would go undiagnosed. Lifestyle interventions also provide an opportunity for
incarcerated women to acquire knowledge and skills for developing healthier diets,
increasing physical activity, and quitting tobacco use. Moreover, programs like
WISEWOMAN have the potential to improve discharge planning and linkages between
released women and community service.
This study cannot state with certainty whether the observed differences between
incarcerated and nonincarcerated women were the result of differences between the two
groups that existed before the women entered the prison system or whether they were
caused by the incarceration period.
Lifestyle Intervention Effectiveness
Lifestyle intervention sessions and intervention programs that are tailored
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according to a woman’s readiness to change, culture, age, location, and access are a
promising approach to improving the cardiovascular health of low-income uninsured
women. Lifestyle interventions also provide an opportunity for underinsured women to
acquire knowledge and skills for developing healthier diets, increasing physical activity,
and decreasing tobacco use (South Dakota Department of Health, 2008). Moreover,
programs like WISEWOMAN have the potential to improve linkages between women
and community service providers (South Dakota Department of Health, 2008). A heart
disease screening and intervention program is a promising strategy for reducing the
burden of cardiovascular disease among women in the United States (South Dakota
Department of Health, 2008). Many of the intervention programs used have a theoretical
construct based on behavioral change models such as the health belief model, the
transtheoretical model of change, and the socioecological model (South Dakota
Department of Health, 2008). Many programs use motivational interviewing to identify
individual risk-level, behavioral goals, and readiness to change (South Dakota
Department of Health, 2008). An individual’s readiness to change then determines the
intensity and emphasis of the intervention program and the strategies that will be utilized
to promote sustainable lifestyle changes (South Dakota Department of Health, 2008).
Lifestyle intervention programs targeting high blood pressure, blood glucose, and
cholesterol are very successful in that they can provide free and/or reduced cost
medication to control the elevated levels, while also focusing on individual behavior
change and support. There is also diversity in the literature in terms of the intensity of the
intervention (Ash et al., 2006; Feigenbaum et al., 2005; Jacobs et al., 2004; Keyserling et
al., 2008; Lewis et al., 2004; Logue et al., 2005; Nelson et al., 2002; Pazoki et al., 2007;

51
Staten et al., 2004; Svetkey et al., 2008). The empirical evidence suggested that such
intervention can be effective (Ash et al., 2006; Besculides et al., 2008; Feigenbaum et al.,
2005; Goldstein et al., 2004; Logue et al., 2005; Opdenacker et al., 2008; Pazoki et al.,
2007; Svetkey et al., 2008). Individual support and lifestyle interventions that are
primarily focused upon reduction in BMI or weight loss are producing promising results
as well, although reduction in BMI is not as pronounced as seen in blood pressure, blood
glucose, and total cholesterol (Will & Loo, 2008). More research is needed in this area to
determine what factors contribute to the positive effects of such interventions over an
extended period of time.
Summary of Methodological Differences in WISEWOMAN Studies
Currently, eight studies have been reported, seven were randomized control trials
and one was a case control study. All studies used the same biomarkers as dependent
variables. Currently, there has not been any previous study has been a quasi experiment
demonstrating how well the program works when translated into real-world practice.
Of the eight total WISEWOMAN studies that focused on change in biomarkers,
six of them demonstrated positive results in that the interventions were effective. The
methods used in previous WISEWOMAN studies differ greatly based on location, sample
size, demographics, random assignment, intervention intensity, longevity and funding
level, as well as the overall analysis.
Summary and Conclusion
The results of the research highlighted above illustrated a need to implement heart
disease factor screening and education programs, such as WISEWOMAN, into state
health departments in effort to expand the reach of the program and identify and serve
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more at-risk women. Specifically, screenings help to identify cases of abnormal blood
pressure and total cholesterol that otherwise would go undiagnosed. Lifestyle
interventions also provide an opportunity for underinsured women to acquire knowledge
and skills for developing healthier diets, increasing physical activity, and quitting tobacco
use. Moreover, programs like WISEWOMAN have the potential to improve linkages
between women and community service providers. A heart disease screening and
intervention program is a promising strategy for reducing the burden of cardiovascular
disease among women in the United States.
WISEWOMAN research has supported the effectiveness of the screening sessions
and lifestyle interventions in preventing chronic disease at 10 to14 months; however, no
studies have quantitatively examined whether LSI sessions and screenings or clinical
screenings alone lead to improvements in blood pressure, blood glucose, total cholesterol,
and/or BMI. There is also a gap in the research related to WISEWOMAN facilitated
maintenance of health behavior beyond the 10 to14 month follow-up screening. In
addition, not enough is known about the effectiveness of lifestyle change programs in
populations containing substantial numbers of American Indians. The purpose of this
retrospective longitudinal study was to quantitatively examine whether LSI sessions and
screenings or clinical screenings alone lead to improvements in blood pressure, blood
glucose, total cholesterol, and/or BMI in an especially vulnerable group.

CHAPTER 3:
RESEARCH METHODS
Introduction
This chapter provides a description of the research methods used in this
dissertation. The purpose of the study, research design and approach, conceptual and
measurement models, statistical methods, as well as protection of human subjects is
reviewed in chapter three. Cardiovascular disease and risk factors leading to
cardiovascular disease disproportionately affect women in certain South Dakota
populations, such as ethnic minority populations and those from low-income
backgrounds, who have a greater burden of chronic disease and lifestyle related risk
factors.
Maintenance of health behavior change is a public health challenge, particularly
for those populations suffering from health disparities. While the quality of life and
chronic disease risk reduction benefits of healthy eating and regular physical activity are
well understood, the ability to promote adherence to a lifetime of these health behaviors
is limited (Institute of Medicine, 2001). The major problem is that while intervention
strategies that lead to adoption of healthy behaviors are well-developed, our knowledge
of how to facilitate sustained health behavior is poorly understood. More research is
needed in this area if health disparities among the South Dakota WISEWOMAN
population are to be reduced or eliminated.
This research elucidated whether health outcomes among women who attend a
combination of LSI sessions and clinical screenings or clinical screenings alone lead to
statistically significant improvements in blood pressure, blood glucose, total cholesterol,
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and/or BMI as measured at rescreening 10 to14 months from initial screening.
Understanding which method (screenings sessions alone or screening sessions along with
LSI) has the greater influence on biological outcomes, influences the design of more
effective public programs aimed at improving the health in population groups similar to
those served in South Dakota.
The purpose of this retrospective longitudinal study was to quantitatively examine
whether the combination of LSI sessions and clinical screenings or clinical screenings
alone lead to improvements in blood pressure, blood glucose, total cholesterol, and/or
BMI as measured at rescreening 10 to14 months from initial screening.
Research Design and Approach
This quantitative retrospective longitudinal study examined whether the
combination of LSI sessions and clinical screenings or clinical screenings alone lead to
improvements in blood pressure, blood glucose, total cholesterol, and/or BMI as
measured at rescreening 10 to14 months from initial screening. The independent variable
was participation in screening session and Lifestyle intervention sessions or only
screening sessions. The dependent variables were blood glucose, blood pressure, total
cholesterol, and BMI. This dissertation study used secondary data and as such, the
researcher did not have any contact with participants; she only used previously collected
data for analysis.
It was assumed that, within the context of this research study, all participants were
South Dakota female residents that met the age and income requirements for program
enrollment. However, to assess this assumption age was examined in the data analysis. It
was also essential to assume that the lab results and measurements of blood pressure,
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blood glucose, BMI, and total cholesterol were accurate, as all clinics receive on-going
training and follow the guidelines set forth by the program.
The conceptual model for the study is shown in Figure 2. The diagram model is
based on the socioecological model. Outcome biomarkers were hypothesized to be
determined primarily by baseline values of the same measures. Health behaviors also
affect biomarkers at follow-up, as do social and demographic factors. The intervention
sessions were expected to impact the rescreening results among the women and therefore
it was logical to assume that the interventions produce positive change among
participants.

Conceptual Model for the Study

Group: LI or Screening

Behavioral Risk Factors at Baseline

Outcome values for blood
glucose, blood pressure,
total cholesterol, and
BMI

Socio-demographic: marital status, age,
employment, and education

Behavioral Risk Factors
Biological: baseline values for blood glucose,
blood pressure, total cholesterol, and BMI

after intervention

Figure 2. Conceptual model for the study.
The conceptual model has been converted into a measurement model that drives
the analysis of the data (Figure 3). The effects of baseline values of the biomarkers were
controlled using change scores. The interventions were assumed to affect change in
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biomarkers independently. Social and demographic variables were used to adjust for
potential confounding that arose because of their effects via unmeasured health
behaviors. The relationship between socio-demographic variables and behavioral change
is shown as a dashed line because it is unmeasured.

Measurement Model for the Study
GROUP: LI or
Screening Only

Change in
biomarkers: blood
glucose, blood
pressure,
cholesterol, BMI

SOCIO-DEMOGRAPHIC:
marital status, age,
employment, education

Figure 3. Measurement model for the study.
Study Limitations
The lack of a random sample weakened external validity. Not using random
assignment of subjects to groups weakens internal validity, as does omission of health
behavior variables. The women self-select and without randomization to groups, it is
difficult to discern the extent to which the intervention attendance truly impacted the
outcomes.
Participant Inclusion/Exclusion Guidelines
Eligible participants included 653 low income women aged 30 to 64 enrolled in
the South Dakota AWC! program from 2000 to 2005 that participated in both the
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screening and rescreening 10 to14 months later. There were a total of 423 in the
screening session only cohort and 230 in the intervetnion cohort. The women in the
intervention cohort had to attend a minimum of one LSI session to be included in the
intervention cohort. There were 69 women who did not have any elevated or alert levels
for blood pressure, blood glucose, cholesterol and/or BMI. The inclusion criteria included
South Dakota women aged 30 to 64 that met WISEWOMAN income guidelines for
enrollment. The income guidelines are set by the Health and Human Services (HHS) and
SD uses the 200% poverty level. The age guidelines were set by the CDC. South Dakota
has been allowed to include women beginning at age 30 because of the smaller
population base. In order to reach the number of women that the CDC mandates states to
screen, South Dakota was granted permission to decrease the age for inclusion. The upper
limit for inclusion was 64 years of age. This was because at age 65 a person is eligible for
Medicare Part B. The exclusion criteria included nonSouth Dakota residents that did not
meet enrollment guidelines and those who were not recreened 10 to14 months after initial
screening. There were not any women excluded from this study because of ineligibility.
Sample Size
A power analysis was conducted to determine the minimum number of
participants needed in this study to detect statistical significance (Cohen, 1988). Several
models were examined using simultaneous multiple regression. All models tested
whether the independent variables (group, age, work status, full-time work status, marital
status, number of dependents, education, income, race, ethnicity, smoking status)
predicted the four dependent variables (change in blood pressure, change in BMI, change
in total cholesterol, and change in blood glucose). A medium effect size was chosen for
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the power analysis based on what had been found in previous WISEWOMAN
evaluations and what was considered clinically relevant. The α for the test of this model
was set at .05. To achieve power of .80 and a medium effect size (f 2=.15), a sample size
of 123 was required to detect a statistically significant regression model (F (11,111) =
1.87). The existing sample size of 653 women provided 100% power to detect
significance (F (11, 641) = 1.80. The study had enough statistical power to detect an
effect, given that the effect actually exists.
Study Procedures
This dissertation study used a census sample of all WISEWOMEN participants
from 2000 to 2005. The data is obtained at initial screening and then at rescreen for
women enrolled in the SD WISEWOMEN program. The method of inquiry used was to
query the WISEWOMEN database that is developed and maintained by MAX TRAC
Data Systems, Inc. located in Minneapolis, MN. MaxTrac has been South Dakota's data
management contractor since 1997. The MaxTrac system provides a secure method of
maintaining and tracking participants, decreasing loss to follow up. This dissertation
study used secondary data analysis to assess change scores in blood pressure, BMI, blood
glucose, and cholesterol among SD WISEWOMAN participants.
Instrumentation
The dependent variables in this dissertation study were change in BMI, change in
total cholesterol, change in blood pressure (both systolic and diastolic), and change in
blood glucose level. These variables have previously been shown to be valuable
indicators of cardiovascular disease risk and have been used in evaluations of lifestyle
interventions, as shown in the literature review for this study. Independent variables
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included items drawn from the AWC! assessment form, which addresses the
participant’s personal health history. Information requested included information about
demographic variables such as age, race, marital status, ethnicity, education,
employment, and insurance status. The researcher, the state of South Dakota’s chronic
disease epidemiologist, serves the SD WISEWOMAN program and is directly involved
with data analysis and program evaluation, therefore having access to all WISEWOMAN
data.
Data Recoding
The strategy for recoding each variable included in the analysis can be found in
Table 2 and Table 3.
Table 2
Recoding of Independent Variables
Variable

Measure

Recoding

Age

Age in years

Marital Status

Married/Not Married

Recoded Based upon distribution (18-34.9,
35-49.9, 50-64.9, 65 and over)
the unmarried categories were combined

Work Status

Employed? (Yes/No)

the unemployed categories were combined

Full-time work Works full time (Yes/No)
Status
Income
Yearly household income in dollars

None
Was recoded into categorical variables
based on quartiles
Less than HS, High school degree, 2-yrs
post HS, 4-year college degree or more.

Education

Highest education completed

Dependents

# of dependents in the household

Race
Ethnicity

Asian, Black, American Indian, White, Other Was recoded into White, American Indian,
and Other
Hispanic (Yes/No)
None

Group

Participation in LSI (Yes/No)

Smoking Status Do you smoke (Yes/No)

None

None
None
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Table 3
Recoding of Dependent Variables
Variable

Measure

Recoding

blood glucose

change in blood glucose from pre-posttest. Blood glucose at follow-up –blood glucose
at intake

blood pressure

change in systolic blood pressure from pre- Systolic blood pressure at follow-up –
posttest.
systolic blood pressure at intake

blood pressure

change in diastolic blood pressure from pre- Diastolic blood pressure at follow-up –
posttest.
diastolic pressure at intake

Total cholesterol change in total cholesterol from pre-posttest. Total cholesterol at follow-up - total
cholesterol at intake
Body Mass Index change in BMI from pre-posttest.

BMI at follow-up - BMI at intake

Statistical Analysis
Data were obtained from MaxTrac in Excel spreadsheets and imported into SPSS
15.0. The data were cleaned and any outliers were identified and removed. Data were
recoded as necessary, especially in cases of skewness. Descriptive statistics (e.g., mean,
standard deviation for continuous variables, frequency, and percentages for categorical
variables) were computed for each variable. Change scores were computed for all
dependent variables (change in blood glucose levels, change in BMI, change in total
cholesterol levels, change in blood pressure). Pearson correlation was used to examine
the degree of association between the continuous independent and dependent variables
(e.g., age and blood pressure). The association between the dependent variables and the
categorical variables were examined using ANOVA unless variances were unequal, in
which case the Kruskal-Wallis analysis of ranks was employed.

61
Multiple linear regression analysis was used to examine the research questions
and corresponding hypotheses. The first regression model examined the ability of the
independent variables (group, age, work status, full-time work status, marital status,
number of dependents, education, income, race, ethnicity, smoking status) to predict
change in blood glucose levels. The second regression model examined the ability of the
independent variables to predict change in BMI. The third regression model examined the
ability of the independent variables to predict change in total cholesterol levels. The
fourth and final regression model examined the ability of the independent variables to
predict change in blood pressure. The regression models were run for those women who
had elevated or alert blood pressure, blood glucose, total cholesterol, and/or BMI levels at
the initial screening session. The elevated value for blood pressure is classified as
>140/90 but <180/110 mm Hg, while an alert value is >180/110 mm Hg. The elevated
value for total cholesterol is >= 200 mg/dl, while the alert value is >= 400mg/dl. The
elevated value for blood glucose (Fasting Plasma Glucose Test) is >= 126mg/dl, while
the alert value is >= 200 mg/dl. A BMI between 25 and 29.99 is classified as overweight,
while a BMI of 30 or above is classified as obese or alert value includes blood pressure
greater or equal to 140 systolic and/ or 90 diastolic (140/90), total cholesterol 200 mg/dl
or greater, blood glucose 126 or greater, and BMI of 25 or greater. The modeling strategy
retained all predictors in the equations. If the confidence interval was excessively broad
for a particular coefficient, the variable was recoded to reduce sparseness in the data. If
the model was unstable, variables with high p values were dropped. Quadratics were
entered to test for nonlinear relationships.
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Protection of Human Subjects
The raw data were provided to the researcher from MaxTrac, the contracted data
manager for the SD WISEWOMAN program. The researcher was able to obtain those
data because of her position as the Chronic Disease Epidemiologist (serving as
epidemiological support for the SD WISEWOMAN program) for the South Dakota
Department of Health. Those data did not include any unique identifying information
such as names or addresses. To protect the rights of human subjects, institutional review
board approval was sought at Walden University before any data analysis began. This
dissertation study used secondary data and as such, the researcher did not have any
contact with participants; she only used previously collected data for analysis.
In the original study on which this dissertation is based, all participants completed an
informed consent form prior to participating in the intervention. The original consent
form explained the purpose of the study, the potential risks, the voluntary nature of
participation, and procedures to ensure participant confidentiality. The data were
analyzed and results were reported at the group level. The CDC does not require
additional IRB approval for the release of these data. The CDC, as well as the South
Dakota Department of Health have already granted permission to use existing
quantitative clinical data from 2000 to 2005.The dataset OMB number is 0920-0612 at
CDC and it is a nonresearch dataset, so IRB approval is not needed.
All study records were kept private. Any report the researcher might publish will
not include any information that could make it possible to identify the study participants.
No names were used in any reports or publications generated from this dissertation and
all data were reported at the group level. The electronic data files were kept in a password
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protected file on a password-protected computer located in the researcher’s office and
data files will be saved for up to seven years; only the researcher has access to these files.

CHAPTER 4:
RESULTS
Purpose of the Study
The purpose of this retrospective longitudinal study was to examine quantitatively
whether the combination of LSI sessions and clinical screenings or clinical screenings
alone lead to improvements in blood pressure, blood glucose, total cholesterol, and/or
BMI as measured at rescreening 10 to 14 months from initial screening. This study
provided information to the SD WISEWOMEN program regarding the effectiveness of
LSI support for clinical screening as opposed to clinical screening alone to improve
health. The data obtained influence future program implementation decisions and serve as
a model of WISEWOMAN program evaluation for the CDC.
Research Questions and Hypotheses
The primary research questions that were addressed in this dissertation include:
1. Is the change in blood glucose level, as measured at rescreening 10 to14
months from initial screening, different for women enrolled in the South Dakota
WISEWOMAN program lifestyle intervention than women receiving clinical screenings
only?
2. Is the change in BMI, as measured at rescreening 10 to14 months from initial
screening, different for women enrolled in the South Dakota WISEWOMAN program
lifestyle intervention than women receiving clinical screenings only?
3. Is the change in total cholesterol level, as measured at rescreening 10 to14
months from initial screening, different for women enrolled in the South Dakota
WISEWOMAN program lifestyle intervention than women receiving clinical screenings
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only?
4. Is the change in blood pressure level, as measured at rescreening 10 to14
months from initial screening, different for women enrolled in the South Dakota
WISEWOMAN program lifestyle intervention than women receiving clinical screenings
only?
This chapter provides the results of the data analysis. The results are presented in
the following order: sample descriptive statistics for the entire sample, univariate, and
multivariate findings; descriptive statistics for the elevated sample only, univariate, and
multivariate findings. High blood pressure is defined as having systolic blood pressure
equal to or greater than 140 mmHg or diastolic blood pressure equal to or greater than 90
mmHg, or taking medication for high blood pressure. High cholesterol is defined as
having total cholesterol equal to or greater than 240 mg/dl or taking medication for high
cholesterol. Overweight is defined as having a BMI of 25 to 29.9, while obese is defined
as having a BMI equal to or greater than 30. BMI is calculated using CDC standards:
BMI = (weight in pounds) divided by (ht in inches squared) times (703). Prediabetes is
defined as a fasting blood glucose of 100 to125mg/dl or a nonfasting glucose of 140 to
199 mg/dl. Diabetes is defined as a fasting blood glucose equal to or greater than
126mg/dl or a nonfasting glucose equal to or greater than 200 mg/dl or history of diabetes
or taking medication for diabetes. The LSI sessions offer women with elevated or alert
screening values up to four lifestyle interventions. The elevated value for blood pressure
is classified as >140/90 but <180/110 mm Hg, while an alert value is >180/110 mm Hg.
The elevated value for total cholesterol is >= 200 mg/dl, while the alert value is >=
400mg/dl. The elevated value for blood glucose (Fasting Plasma Glucose Test) is >=
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126mg/dl, while the alert value is >= 200 mg/dl. A BMI between 25 and 29.99 is
classified as overweight, while a BMI of 30 or above is classified as obese or alert value
includes blood pressure greater or equal to 140 systolic and/ or 90 diastolic (140/90), total
cholesterol 200 mg/dl or greater, blood glucose 126 or greater, and BMI of 25 or greater.
Replacement of Missing Values
Missing values for independent variables that were measured on either a nominal
or ordinal scale were replaced. Specifically, the median was used to replace the missing
values. There were only seven cases with missing data. No comparisons were made
between this subset and the entire sample. Replacement of missing values was
implemented to be in compliance with other WISEWOMAN research studies.
Univariate Test Results
WISEWOMAN Lifestyle Intervention and the Independent Variables
Univariate tests for the independent variables are presented below.
BMI. The means and standard deviations for the BMI change scores across
conditions, control (screening session only) vs. intervention (screening sessions with
lifestyle intervention sessions) and BMI categories (i.e., overweight, obese, and morbidly
obese) are displayed in Table 4. As can be gleaned from Table 4, the mean BMI change
score for participants classified as overweight (in both control and intervention groups)
was negative. The mean change score for participants classified as obese was negative
only for those in the control group but was positive for those in the intervention group.
Across both groups, the mean change score for participants classified as morbidly obese
was positive.
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The findings in Table 5 reveal that, first, BMI change scores did not vary
significantly across conditions (F (1,453) = 2.509, p = .114). The mean change score of
the control group (M = .05) was similar to the mean change score of the intervention
group (M = .25). Second, there was a significant main effect for BMI categories (F
(1,453) = 4.727, p = .009). Post-hoc Tukey test procedures reveal that the BMI change
scores of overweight participants varied significantly (M = -.29) from the change scores
of obese participants (M = .25; p = .046). Third, the effect of the intervention on BMI
change scores did not vary across BMI categories (F (2,453) = 1.625, p = .198).
Table 4
Means and Standard Deviations of BMI Change Scores (N = 454)
BMI Category

Control
Mean

Intervention
SD

Mean

SD

Overweight

-.23

2.11

-.43

1.60

Obese

-.04

1.82

.61

2.38

.11

1.96

.58

2.60

Morbidly obese

Table 5
Two-Way ANOVA Results for BMI Change Scores
Source

df

F

Sig.

Intervention

1

2.509

.114

BMI category

2

4.727

.009

Intervention x BMI category

2

1.625

.198

Error

453
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Table 6
Independent t test Results for BMI Change Scores within BMI Categories
BMI Category

df

t

Sig.

Overweight

177

.669

.504

Obese

129

-1.780

.077

Morbidly obese

149

-1.228

.222

Cholesterol. The means and standard deviations for the cholesterol change scores
across conditions and cholesterol levels are presented in Table 7. As shown in Table 7,
the mean cholesterol change score for subjects with normal cholesterol levels (in the
control and intervention groups) was positive. However, the mean cholesterol change
score for subjects with elevated cholesterol levels (in both groups) was negative.
The findings in Table 8 suggest that, first, cholesterol change scores did not vary
significantly across conditions (F (1,646) = .000, p = .989); thus, participants in both the
control and intervention groups had similar change scores. Second, cholesterol level
change scores varied significantly across cholesterol levels (F (1,646) = 69.754, p =
.000). In particular, the mean change score of participants classified as having a normal
cholesterol level was significantly higher (M = 10.33) than the mean change score of
participants classified as having an elevated cholesterol level (M = -12.51). Third, the
findings indicate that the effect of the intervention on cholesterol level change scores did
not vary across cholesterol levels (F (1,646) = .322, p = .571).
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Table 7
Means and Standard Deviations of Cholesterol Change Scores (N = 647)
Cholesterol Category

Control
Mean

Intervention
SD

Mean

SD

Normal

11.12

31.54

9.53

29.26

Elevated

-13.27

35.97

-11.75

32.83

Table 8
Two-Way ANOVA Results for Cholesterol Change Scores
Source

df

F

Sig.

Intervention

1

.000

.989

Cholesterol levels

1

69.754

.000

Intervention x cholesterol levels

1

.322

.571

Error

646

Systolic blood pressure. The means and standard deviations for the systolic
change scores across conditions and blood pressure levels are displayed in Table 9. As
shown in Table 9, the mean systolic blood pressure change scores were negative; only the
mean change score of participants classified as having normal systolic blood pressure in
the intervention group was positive.
The findings in Table 10 reveal that systolic blood pressure change scores did not
vary significantly across conditions (F (1,626) = .245, p = .621). Similarly, systolic blood
pressure change scores did not vary significantly across blood pressure groups (F (1,626)
= .047, p = .828). Further, the effect of the intervention on systolic blood pressure change
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scores did not vary across blood pressure groups (F (1,626) = .428, p = .513).
Table 9
Means and Standard Deviations of Systolic BP Change Scores (N = 627)
Blood Pressure Group

Control
Mean

Intervention
SD

Mean

SD

Normal

-1.11

12.55

.77

12.43

Elevated

-.40

21.25

-.66

28.42

Table 10
Two-Way ANOVA Results for Systolic BP Change Scores
Source

df

F

Sig.

Intervention

1

.245

.621

Blood pressure group

1

.047

.828

Intervention x blood pressure group

1

.428

.513

Error

626

Diastolic blood pressure. The means and standard deviations for the diastolic
change scores across conditions and blood pressure levels are presented in Table 11. As
shown in Table 11, the mean diastolic blood pressure change scores were negative; only
the mean change score of participants classified as having normal diastolic blood pressure
in the intervention group was positive.
The findings in Table 12 indicate that diastolic blood pressure change scores did
not vary significantly across conditions (F (1,626) = .071, p = .790). Second, diastolic
blood pressure change scores did not vary significantly across blood pressure groups (F
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(1,626) = .134, p = .714). Lastly, the effect of the intervention on diastolic blood
pressure change scores did not vary across blood pressure groups (F (1,626) = .636, p =
.426).
Table 11
Means and Standard Deviations of Diastolic BP Change Scores (N = 627)
Blood Pressure Category

Control
Mean

Intervention
SD

Mean

SD

Normal

-.56

9.75

.05

10.70

Elevated

-.06

11.44

-1.29

16.51

Table 12
Two-Way ANOVA Results for Diastolic BP Change Scores
Source

df

F

Sig.

Intervention

1

.071

.790

Blood pressure group

1

.134

.714

Intervention x blood pressure group

1

.636

.426

Error

626

Glucose. The means and standard deviations for the glucose change scores across
conditions and glucose levels are displayed in Table 13. The mean glucose change scores
for participants classified as having normal glucose levels was positive – thus indicating
an increase in glucose levels across time. The mean glucose change scores for
participants classified as having elevated glucose levels was negative – thus indicating a
decrease in glucose levels across time.
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The findings in Table 14 reveal that, first, glucose change scores varied
significantly across conditions (F (1,560) = 4.287, p = .039). In particular, the mean
change score of participants in the control group (M = -12.34) varied significantly from
the mean change score of participants in the intervention group (M = -2.81); thus, glucose
levels dropped more for participants in the control group. Second, glucose change scores
varied significantly across glucose levels (F (1,560) = 20.867, p = .000). The mean
change score of participants with normal glucose levels (M = 2.94) varied significantly
from the mean change score of participants with elevated glucose levels (M = -18.08);
thus, glucose levels dropped only for participants with elevated glucose levels. Third, the
findings indicate that the effect of the intervention on glucose change scores varied across
glucose levels (F (1,560) = 4.597, p = .032). As shown in Table 15, the intervention had a
stronger (but not significant) effect on glucose change scores only for participants with
elevated glucose levels (t (42) = -791, p = .433). Contrary to expectations, however, a
larger change was observed in the control condition (M = -27.78; SD = 91.51) in
comparison to the intervention condition (M = -8.38; SD = 71.07).
Table 13
Means and Standard Deviations of Glucose Change Scores (N = 561)
Glucose Levels

Control

Intervention

Mean

SD

Mean

SD

Normal

3.11

18.12

2.77

21.50

Elevated

-27.78

91.51

-8.38

71.07
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Table 14
Two-Way ANOVA Results for Glucose Change Scores
Source

df

F

Sig.

Intervention

1

4.287

.039

Glucose levels

1

20.867

.000

Intervention x glucose levels

1

4.597

.032

Error

560

Table 15
Independent t test Results for Glucose Change Scores within Glucose Levels
Glucose Levels

df

t

Sig.

Normal

518

.189

.850

Elevated

42

-.791

.433

The Relationship between Marital Status and BMI, Cholesterol Levels, Blood Pressure,
and Glucose Levels
The findings in Tables 16 and 17 reveal that BMI change scores did not vary
significantly across marital status (t (605) = -.859, p = .391). Cholesterol change scores
varied significantly across marital status (t (648) = 2.185, p = .029). The mean cholesterol
change score for women who were not married was positive (M = 1.33; SD = 39.15), thus
indicating that the mean cholesterol score for these women increased postscreening. The
mean cholesterol change score for women who were married was negative (M = -4.78;
SD = 31.20), thus indicating that the mean cholesterol score for these women decreased
postscreening. Systolic blood pressure change scores did not vary significantly across
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marital status (t (627) = .556, p = .578); diastolic blood pressure change scores did not
vary significantly across marital status (t (627) = 1.295, p = .196); and glucose level
change scores also did not vary significantly across marital status (t (562) = -.979, p =
.328).
Table 16
Means and Standard Deviations of Change Scores across Marital Status Groups
Change Score

Not Married

Married

Mean

SD

Mean

SD

BMI

-.15

2.11

-.02

1.73

Cholesterol level

1.33

39.15

-4.78

31.20

Systolic blood pressure

-.15

14.99

-.83

15.68

Diastolic blood pressure

.17

10.89

-.94

10.58

Glucose level

.36

22.60

2.78

35.36

Table 17
Independent t test Results for Change Scores across Marital Status Groups
Change Score

df

t

Sig.

BMI

605

-.859

.391

Cholesterol level

648

2.185

.029

Systolic blood pressure

627

.556

.578

Diastolic blood pressure

627

1.295

.196

Glucose level

562

-.979

.328
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The Relationship between Ethnicity and BMI, Cholesterol Levels, Blood Pressure, and
Glucose Levels
The findings in Tables 18 and 19 reveal that BMI change scores did not vary
significantly across ethnic groups (t (606) = .334, p = .738). Cholesterol change scores
also did not vary significantly across ethnic groups (t (649) = -1.063, p = .288). However,
systolic blood pressure change scores varied significantly across ethnic groups (t (628) =
2.148, p = .032). The mean systolic blood pressure change score for Non-White women
was positive (M = 2.61; SD = 14.30), thus indicating that the mean systolic score for
these women increased postscreening. The mean systolic blood pressure change score for
White women was negative (M = -1.02; SD = 15.42), thus indicating that the mean
systolic score for these women decreased postscreening. Diastolic blood pressure change
scores; however, did not vary significantly across ethnic groups (t (628) = 1.453, p =
.147). Lastly, glucose level change scores did not vary significantly across ethnic groups
(t (562) = 1.211, p = .226).
Table 18
Means and Standard Deviations of Change Scores across Ethnic Groups
Change Score

NonWhite

White

Mean

SD

Mean

SD

BMI

-.03

1.97

-.10

1.93

Cholesterol level

-5.05

34.62

-.93

35.88

Systolic blood pressure

2.61

14.30

-1.02

15.42

Diastolic blood pressure

1.09

11.75

-.63

10.57

Glucose level

5.00

43.66

.85

25.83
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Table 19
Independent t test Results for Change Scores across Ethnic Groups
Change Score

df

T

Sig.

BMI

606

.334

.738

Cholesterol level

649

-1.063

.288

Systolic blood pressure

628

2.148

.032

Diastolic blood pressure

628

1.453

.147

Glucose level

562

1.211

.226

The Relationship between Level of Education and BMI, Cholesterol Levels, Blood
Pressure, and Glucose Levels
Although level of education initially consisted of six levels, due to small sample
sizes in some categories, levels were collapsed to arrive at four levels. The first two
levels (i.e., some high school and high school) were combined into a single category. The
third and fourth levels (i.e., some technical school and some college) were grouped into a
single category.
As shown in Tables 20 and 21, BMI change scores, systolic blood pressure
change scores, diastolic blood pressure change scores; cholesterol change scores, and
glucose level change scores did not vary significantly across levels of education.
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Table 20
Means and Standard Deviations of Change Scores across Levels of Education
Change Score

Some High School or

Some Technical

Technical School

College

High School Graduate

School or College

Graduate

Graduate

Mean

SD

Mean

SD

Mean

SD

Mean

SD

BMI

.03

1.90

-.26

1.81

-.32

2.18

.23

2.11

Cholesterol

-4.63

38.20

4.33

30.44

.55

33.95

1.37

31.25

-.81

15.49

-.94

15.47

1.41

15.38

.46

13.93

-.48

11.13

-.83

10.27

.45

9.90

.59

10.36

.39

31.59

4.14

32.15

2.02

18.02

1.49

11.62

level

Systolic blood
pressure

Diastolic blood
pressure

Glucose level
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Table 21
ANOVA Results for Change Scores across Levels of Education
Change Score

MS

df

F

Sig.

Between groups

4.514

3

1.205

.307

Within groups

3.746

603

Between groups

3127.783

3

2.468

.061

Within groups

1267.203

646

Between groups

121.655

3

.518

.670

Within groups

234.873

625

Between groups

43.059

3

.371

.774

Within groups

115.912

625

Between groups

447.659

3

.522

.667

Within groups

857.611

560

BMI

Cholesterol level

Systolic blood pressure

Diastolic blood pressure

Glucose level
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The Relationship between Age and BMI, Cholesterol Levels, Blood Pressure, and
Glucose Levels
Age was measured continuously but was transformed into a categorical variable.
The whole sample was divided into three groups using the values at the 33rd and 66th
percentiles. These percentiles were chosen so that the sample could be divided into three
equal groups. Accordingly, women aged 38 years and younger were assigned to the first
category; women between 39 and 48 were grouped into the second category; and women
49 years and older were assigned into the third category.
As can be gleaned from the findings in Tables 22 and 23, BMI change scores did
not vary significantly across age groups (F (2,605) = .826, p = .438). Second, cholesterol
change scores varied significantly across age groups (F (2,648) = 3.327, p = .037). The
findings from a linear trend analysis reveal that cholesterol change scores increased
across age groups (F (1,468) = 4.399, p = .036). Third, systolic blood pressure change
scores did not vary significantly across age groups (F (2,627) = 1.445, p = .237). Fourth,
diastolic blood pressure change scores also did not vary significantly across age groups
(F (2,627) = 2.315, p = .100). Lastly, glucose level change scores did not vary
significantly across age groups (F (2,561) = .048, p = .953).
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Table 22
Means and Standard Deviations of Change Scores across Age Groups
Change Score

38 and Younger

39 to 48

49 and Older

Mean

SD

Mean

SD

Mean

SD

BMI

-.17

2.13

-.16

1.98

.05

1.68

Cholesterol level

2.35

29.03

-.40

33.37

-6.23

42.18

Systolic blood pressure

1.09

13.21

-1.20

15.79

-1.11

16.42

Diastolic blood

1.01

9.47

-1.02

11.10

-.92

11.41

pressure
.
Glucose level

1.56

26.98

1.87

32.80

98

27.36
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Table 23
ANOVA Results for Change Scores across Age Groups
Change Score

MS

df

F

Sig.

Between groups

3.101

2

.826

.438

Within groups

3.753

605

Between groups

4207.498

2

3.327

.037

Within groups

1264.805

648

Between groups

337.613

2

1.445

.237

Within groups

233.639

627

Between groups

267.079

2

2.315

.100

Within groups

115.393

627

Between groups

41.062

2

.048

.953

Within groups

858.329

561

BMI

Cholesterol level

Systolic blood pressure

Diastolic blood pressure

Glucose level

82
The Relationship between Smoking and BMI, Cholesterol Levels, Blood Pressure, and
Glucose Levels
The findings in Tables 24 and 25 indicate that, first, BMI change scores varied
significantly across smoking groups (F (2,603) = 4.610, p = .010). Post-hoc Tukey test
findings; however, did not yield any significant group comparisons. Further examination
of the means in Table 24 reveals, however, that the mean BMI score of participants who
smoked occasionally dropped the most across time (M = -.72) in comparison to
participants who did not smoke at all (M = .05) and participants who smoked everyday
(M = -.41). Second, cholesterol change scores did not vary significantly across smoking
groups (F (2,645) = .718, p = .488). Third, systolic blood pressure change scores also did
not vary significantly across smoking groups (F (2,626) = .103, p = .902). Fourth,
diastolic blood pressure change scores did not vary significantly across smoking groups
(F (2,626) = .201, p = .818). Finally, glucose level change scores changed marginally
across smoking groups (F (2,558) = 2.892, p = .056). Examination of the means in Table
24 suggests that the mean glucose score of participants who did not smoke at all
increased the least across time (M = .40) in comparison to participants who smoked
occasionally (M = 13.38) and participants who smoked everyday (M = 3.29).
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Table 24
Means and Standard Deviations of Change Scores across Smoking Groups
Change Score

Not at All

Some Days

Everyday

Mean

SD

Mean

SD

Mean

SD

BMI

.05

1.95

-.72

2.00

-.41

1.76

Cholesterol level

-2.66

36.07

.11

30.06

1.55

34.93

Systolic blood

-.63

15.50

36

12.71

-.15

15.28

-.53

10.79

-.06

9.53

.12

11.02

.40

27.16

13.38

46.85

3.29

30.81

pressure

Diastolic blood
pressure

Glucose level
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Table 25
ANOVA Results for Change Scores across Smoking Groups
Change Score

MS

df

F

Sig.

Between groups

16.938

2

4.610

.010

Within groups

3.675

603

Between groups

909.982

2

.718

.488

Within groups

1267.521

645

Between groups

24.257

2

.103

.902

Within groups

234.838

626

Between groups

23.297

2

.201

.818

Within groups

116.111

626

Between groups

2459.772

2

2.892

.056

Within groups

850.545

558

BMI

Cholesterol level

Systolic blood pressure

Diastolic blood pressure

Glucose level
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The Relationship between Income and BMI, Cholesterol Levels, Blood Pressure, and
Glucose Levels
As shown in Table 26, BMI change scores were not significantly correlated with
income (r = -.03, p = .435). Cholesterol change scores were not significantly correlated
with income (r = -.01, p = .893). Systolic blood pressure change scores were not
significantly correlated with income (r = -.03, p = .414). Diastolic blood pressure change
scores were not significantly correlated with income (r = .00, p = .988). Glucose level
change scores were not significantly correlated with income (r = -.01, p = .763).
Table 26
Pearson Correlations between Change Scores and Income
Change Score

r

Sig.

BMI

-.03

.435

Cholesterol level

-.01

.893

Systolic blood pressure

-.03

.414

Diastolic blood pressure

.00

.988

Glucose level

-.01

.763

The Relationship between Number of Dependents and BMI, Cholesterol Levels, Blood
Pressure, and Glucose Levels
The findings in Table 27 reveal that, first, BMI change scores were significantly
correlated with number of dependents (r = .10, p = .014). The more dependents women
had, the lesser was their reduction in BMI. Cholesterol change scores were not
significantly correlated with number of dependents (r = -.03, p = .529). Third, systolic
blood pressure change scores were also not significantly correlated with number of
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dependents (r = -.00, p = .952). Similarly, diastolic blood pressure change scores were
not significantly correlated with number of dependents (r = -.01, p = .738). Lastly,
glucose level change scores were not significantly correlated with number of dependents
(r = .01, p = .780).
Table 27
Pearson Correlations between Change Scores and Number of Dependents
Change Score

r

Sig.

BMI

.10

.014

Cholesterol level

-.03

.529

Systolic blood pressure

-.00

.952

Diastolic blood pressure

-.01

.738

Glucose level

.01

.780

Multivariate Results
The multivariate results are presented in this section.
Overall Procedure
Since level of education was a categorical variable with four groups, three dummy
variables were created. The first category (i.e., those who had some high school or who
graduated from high school) served as the anchor. Second, since age was a categorical
variable with three groups, two dummy variables were created. The first category (i.e.,
the youngest group) served as the anchor. Finally, since smoking was a categorical
variable with three groups, two dummy variables were created. The first category (i.e.,
the nonsmokers) served as the anchor.
A forced-entry procedure was used. Specifically, all demographic variables and
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preintervention screening weight were entered into the equation first. The intervention
variable (with the control serving as the anchor) was entered into the equation last.
Outliers on both the x- and y-space were detected using Cook’s D. Cases whose
Cook’s D values were two standard deviations greater than the Cook’s D mean were
deleted from the analysis. Since the regression results without the two outliers were
similar to the regression results with the outliers, the latter regressions were retained.
The assumptions of normality, linearity, and homoscedasticity were also verified.
The normal probability plots indicated that the distributions were only slightly skewed.
Plots of the standardized predicted values against the dependent variable revealed that
linearity was not violated. Lastly, plots of the standardized predicted values against the
studentized deleted residuals indicated that homoscedasticity was not violated.
Change in BMI Scores
The linear regression findings are shown in Table 28. The number of dependents
women had significantly predicted change in BMI scores (B = .15; F (1,594) = 7.563, p =
.006). The more dependents women had, the lesser was their reduction in BMI
postscreening. Second, BMI prescreening scores also significantly predicted change in
BMI scores (B = .09; F (1,594) = 4.737, p = .030). The higher the BMI prescreening
score, the higher the BMI change score.
After controlling for income, number of dependents, marital status, level of
education, age, smoking status, and prescreening BMI, the WISEWOMAN intervention
did not significantly predict change in BMI scores (B = .03; F (1,594) = .465, p = .495).
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Table 28
Multiple Linear Regression Results for BMI Change Scores (N = 607)
Variable

Beta

F

Sig.

R2

Income

-.03

.245

.621

.000

Number of dependents

.15

7.563

.006

.013

Married vs. not married

-.05

1.067

.302

.002

Some technical/college vs. high school

-.06

1.746

.187

.003

Technical school graduate vs. high school

-.04

1.117

.291

.001

College graduate vs. high school

-.05

1.283

.258

.002

39 to 48 vs. 38 and younger

.05

.914

.339

.002

49 and older vs. 38 and younger

.10

3.814

.051

.006

Occasional smoker vs. nonsmoker

-.07

2.953

.086

.005

Daily smoker vs. nonsmoker

-.05

1.442

.230

.002

Prescreening BMI

.09

4.737

.030

.008

Intervention

.03

.465

.195

.000

2.230

.009

.043

Overall model

Change in Cholesterol Level Scores
The linear regression findings in Table 29 show that level of education
significantly predicted change in cholesterol scores (B = .11; F (1,609) = 7.088, p = .008).
Women who took some high school classes or had graduated from high school had lower
change in cholesterol scores than women who took some technical school or college
classes. Age also significantly predicted change in cholesterol scores (B = -.12; F (1,609)
= 5.421, p = .020). Women aged 38 years and younger had lower change in cholesterol
scores than women aged 49 and older.
After controlling for income, number of dependents, marital status, level of
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education, age, smoking status, and prescreening BMI, the WISEWOMAN
intervention did not significantly predict change in cholesterol scores (B = -.06; F (1,609)
= 2.288, p = .131).
Table 29
Multiple Linear Regression Results for Change in Cholesterol Level Scores (N = 622)
Variable

Beta

F

Sig.

R2

Income

.03

.354

.552

.000

Number of dependents

-.05

.849

.357

.003

Married vs. not married

-.06

1.458

.228

.004

Some technical/college vs. high school

.11

7.088

.008

.008

Technical school graduate vs. high school

.04

.899

.343

.002

College graduate vs. high school

.05

1.384

.240

.003

39 to 48 vs. 38 and younger

-.05

.889

.346

.003

49 and older vs. 38 and younger

-.20

5.421

.020

.040

Occasional smoker vs. nonsmoker

.01

.092

.762

.000

Daily smoker vs. nonsmoker

.03

.364

.547

.000

Prescreening BMI

.04

.970

.325

.002

Intervention

.06

2.288

.131

.004

1.956

.026

.037

Overall model

Change in Systolic Blood Pressure Scores
The findings in Table 30 reveal that none of the demographic variables
significantly predicted change in systolic blood pressure scores. Further, after controlling
for the effects of the demographic variables, the WISEWOMAN intervention did not
significantly predict change in systolic blood pressure scores (B = .04; F (1,596) = 1.057,
p = .304).
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Table 30
Multiple Linear Regression Results for Change in Systolic Blood Pressure Scores (N =
609)
Variable

Beta

F

Sig.

R2

Income

-.03

.476

.491

.000

Number of dependents

.01

.017

.897

.000

Married vs. not married

-.00

.003

.955

.000

Some technical/college vs. high school

-.01

.031

.860

.000

Technical school graduate vs. high school

.05

1.393

.238

.003

College graduate vs. high school

.03

.456

.500

.000

39 to 48 vs. 38 and younger

-.08

2.563

.110

.006

49 and older vs. 38 and younger

-.07

1.743

.187

.005

Occasional smoker vs. nonsmoker

-.01

.054

.816

.000

Daily smoker vs. nonsmoker

.02

.145

.703

.000

Prescreening BMI

-.04

1.045

.307

.002

Intervention

.04

1.057

.304

.002

.675

.776

.013

Overall model

Change in Diastolic Blood Pressure Scores
As shown in Table 31, none of the demographic variables significantly predicted
change in diastolic blood pressure scores. Similarly, after controlling for the effects of the
demographic variables, the WISEWOMAN intervention did not significantly predict
change in diastolic blood pressure scores (B = .02; F (1,609) = .193, p = .661).
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Table 31
Multiple Linear Regression Results for Change in Diastolic Blood Pressure Scores (N =
609)
Variable

Beta

F

Sig.

R2

Income

.03

.282

.595

.000

Number of dependents

-.03

.218

.640

.000

Married vs. not married

-.04

.820

.365

.002

Some technical/college vs. high school

-.02

.270

.603

.000

Technical school graduate vs. high school

.03

.475

.491

.000

College graduate vs. high school

.03

.373

.542

.000

39 to 48 vs. 38 and younger

-.09

3.677

.056

.008

49 and older vs. 38 and younger

-.09

3.090

.079

.008

Occasional smoker vs. nonsmoker

.01

.013

.908

.000

Daily smoker vs. nonsmoker

.02

.198

.656

.000

Prescreening BMI

-.03

.527

.468

.000

Intervention

.02

.193

.661

.000

.668

.783

.013

Overall model

Change in Glucose Level Scores
The linear regression findings in Table 32 indicate that smoking significantly
predicted change in glucose level scores (B = .12; F (1,531) = 6.909, p = .009). Women
who occasionally smoked cigarettes had higher glucose change scores than women who
did not smoke cigarettes. After controlling for the effects of the demographic variables,
the WISEWOMAN intervention did not significantly predict change in glucose level
scores (B = -.00; F (1,531) = .006, p = .941).
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Table 32
Multiple Linear Regression Results for Change in Glucose Level Scores (N = 544)
Variable

Beta

F

Sig.

R2

Income

-.04

.574

.449

.000

Number of dependents

.00

.005

.946

.000

Married vs. not married

.07

2.022

.156

.005

Some technical/college vs. high school

.07

2.153

.143

.005

Technical school graduate vs. high

.01

.016

.898

.000

school

.02

.304

.582

.000

College graduate vs. high school

-.00

.007

.933

.000

39 to 48 vs. 38 and younger

-.00

.001

.969

.000

49 and older vs. 38 and younger

.12

6.909

.009

.014

Occasional smoker vs. nonsmoker

.07

2.244

.135

.004

Daily smoker vs. nonsmoker

.08

3.078

.080

.006

Prescreening BMI

-.00

.007

.934

.000

1.125

.337

.025

Intervention
Overall model

Summary
The results of this analysis did not support hypotheses 1 through 4. The
WISEWOMAN screening session identifies cases of abnormal blood pressure, blood
glucose, total cholesterol, and BMI that otherwise would go undiagnosed; however, the
overall effectiveness of the LSI on blood pressure, blood glucose, total cholesterol, and
BMI is not supported by the analysis.
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The Relationship between Conditions and Outcomes
BMI
There was no significant difference in BMI by condition (intervention vs.
control). The intervention did not have a significant effect on BMI change; however,
there were marginal (but not significant) differences in BMI change scores across the
three BMI categories.

Mean BMI

Mean BMI across Time
(p = .114)
31.2
31.15
31.1
31.05
31
30.95
30.9
30.85
30.8
30.75
30.7

Control
Intervention

Baseline

Outcome
Time

Figure 4. Mean BMI across time.
Total Cholesterol
There was no significant difference in cholesterol by condition (intervention vs.
control); however, there were differences in cholesterol change scores across the two
cholesterol change categories.
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Mean Cholesterol Level across Time
(p = .989)

Mean Cholesterol Level

206
205
204
203
202

Control

201

Intervention

200
199
198
Baseline

Outcome
Time

Figure 5. Mean cholesterol level across time.

Systolic Blood Pressure
There was no significant difference in systolic blood pressure change by condition
(intervention vs. control). There were no differences in systolic blood pressure change
scores across the two systolic categories (normal and elevated).
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Mean Systolic Blood Pressure

Change in Systolic Blood Pressure across Time
(p = .621)
124
123
122

Control
Intervention

121
120
Baseline

Outcome
Time

Figure 6. Change in systolic blood pressure across time.
Diastolic Blood Pressure
There was no significant difference in diastolic blood pressure change by
condition (intervention vs. control). There were no differences in diastolic blood pressure
change scores across the two diastolic categories (normal and elevated). In addition, none
of the diastolic blood pressure groups changed significantly from pre to post.

96

Mean Diastolic Blood Pressure

Change in Diastolic Blood Pressure across Time
(p = .790)
79
78
77

Control
Intervention

76
75
Baseline

Outcome
Time

Figure 7. Change in diastolic blood pressure across time.
Glucose
Glucose change scores varied significantly across conditions (treatment vs.
control) and across glucose levels (normal vs. elevated). The intervention had a stronger
effect, although not statistically significant, on glucose change scores only for
participants with elevated glucose levels. Over time there was a bigger change in the
control condition (M = -27.78) than in the intervention condition (M = -8.38).
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Change in Glucose Level across Time
(p = .039)

Mean Glucose Level

106
104
102
100

Control

98

Intervention

96
94
Baseline

Outcome
Time

Figure 8. Change in glucose level across time.
The following chapter will review the study and present conclusions about the
outcomes. Chapter 5 will also discuss the social change implications of these findings,
the limitations of this study, and future recommendations for continued research in this
area.

CHAPTER 5:
DISCUSSION
Introduction and Summary of the Multivariate Results
In regard to BMI, significant variables emerged as predictors of change in BMI.
The number of dependents women had significantly predicted change in BMI in that the
more dependents women had; the less was their reduction in BMI. The initial screening
BMI significantly predicted change in that the higher the woman’s BMI was at the initial
screening, the greater the decrease in BMI at rescreening. When income, number of
dependents, marital status, education level, age, smoking status, and prescreening BMI
were included in the regression model, the WISEWOMAN intervention did not
significantly predict change in BMI scores, suggesting no differences between the
comparison versus intervention group.
The linear regression indicated that the level of education significantly predicted
change in total cholesterol scores. Women who took some high school classes or had
graduated from high school had less change in cholesterol than women who took some
technical school or college classes. Age also significantly predicted change in cholesterol
scores, in that women aged 38 years and younger had lower change in cholesterol scores
than women aged 49 and older. When income, number of dependents, marital status,
level of education, age, smoking status, and prescreening BMI were included in the
regression model, the WISEWOMAN intervention did not significantly predict change in
cholesterol scores.
The linear regression revealed that smoking significantly predicted change in
glucose level scores. Women who occasionally smoked cigarettes had higher change
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scores than women who did not smoke cigarettes; however, the WISEWOMAN
intervention did not significantly predict change in glucose level scores.
The demographic variables did not significantly predict change in either systolic
or diastolic blood pressure scores.
Comparison to Previously Published Studies of Similar Interventions
The results of this analysis contribute to the knowledge of heart disease risk factor
prevalence among women enrolled in the South Dakota WISEWOMAN program. It was
hypothesized that SD WISEWOMAN participants attending the screening sessions, as
well as the intervention sessions, would have lower levels of blood pressure, blood
glucose, total cholesterol, and obesity at clinical rescreening 10 to14 months later.
Contrary to expectations, the data revealed that differences in blood pressure, blood
glucose, total cholesterol, and BMI were not observed. One possible explanation for this
finding is that the WISEWOMAN screening session alone initiated a woman’s
motivation to change. Other possible explanations for these findings include differences
in study methods, flaws in the transtheoretical model, or lack of perfect fidelity to the
transtheoretical model. The methods included in this study differ from other
WISEWOMAN studies in that there was no assignment to groups (screenings sessions
only or screening sessions with interventions). The women self-selected without
randomization to groups, therefore it is difficult to discern the extent to which
intervention attendance truly impacted the outcomes. Recently there has been an increase
in research denouncing the transtheoretical model because of analytic, conceptual, and
methodological issues. The transtheoretical model of behavior change is a relatively new
behavior theory that does not have the longevity of research to support it, in comparison
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to other theoretical constructs (Bandura, 1997). The WISEWOMAN program is
completely based on the provider site staff and the interventionists. Although numerous
training sessions are provided, as well as a WISEWOMAN policy and procedure manual,
clinicians and interventionists’ adherence to the theoretical foundation of the
WISEWOMAN program is questionable. The WISEWOMAN program administrators
are not able to monitor program fidelity (Hutchison, Breckon, & Johnston, 2008).
Between January 2001 and December 2005, 653 women were screened and
rescreened by the program. Additionally, implementation of programs, such as
WISEWOMAN, is becoming more important as the female population in SD grows older
and the burden of chronic disease increases. This research illustrates the potential value
of additional screening to identify women with abnormal blood glucose, blood pressure,
total cholesterol, and BMI who would not have otherwise been diagnosed. These results
confirm that the WISEWOMAN program presents a unique opportunity to reach
financially vulnerable populations at high risk for chronic and communicable diseases
(Glaser & Greifinger, 1993).
The women in this study self-selected without randomization to groups, therefore
it is difficult to discern the extent to which the intervention attendance truly impacted the
outcomes. Mercer and her colleagues (2007) concluded that utilizing a pre-post in a
quasi-experimental study is useful in investigating the feasibility of an intervention and
are better than a randomized post test. Vandenbroucke et al. (2007) suggested that the
overall generalizability or external validity of a study is significant only with regard to
specific circumstances. Diversity in population, severity of disease, co-occurring
disorders, and exposure all impact external validity. Vandenbroucke et al. also
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acknowledged that using data collected in the past poses as a threat to external
validity in that it is questionable how applicable the results are to the current population.
In six of the eight WISEWOMAN studies, women were randomly assigned to a control
versus intervention group. Furthermore, the rigor of randomized trials is unlikely to be
replicated in real-world situations, which significantly weakens their external validity.
This point is supported by the less impressive findings that were produced from this
natural experiment, which is more realistic than a randomized trial would be. In short, the
design of this study is weaker that most of the others in regard to internal validity but
stronger in regard to external validity.
The sample size for this study consisted of 653 women, which is mid-range
compared to other WISEWOMAN sample sizes. The WISEWOMAN workgroup (1999)
had the largest sample consisting of 4842 women from Massachusetts, Arizona, and
North Carolina. The smallest sample consisted of 217 women from the Arizona
WISEWOMAN project (Staten et al., 2004). This research project categorized the women
into groups based on biomarker results. Women were classified as normal, meaning there
were no elevated levels at time of initial screening or elevated, meaning that they had a
minimum of one elevated biomarker level. To date, there are no other WISEWOMAN
studies that have used this classification in their analysis.
This dissertation evaluated a lifestyle intervention that primarily targeted nutrition
and physical activity to reduce risk of cardiovascular disease, while the other studies
compared and contrasted the minimal versus the enhanced interventions. The enhanced
intervention includes the former, plus one-on-one nutritional and physical activity
assessments and counseling, individual and group education, and behavioral intervention
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activities. Data analysis was similar to other WISEWOMAN studies in that use of
descriptive statistics and regression analysis was a common approach. The dependent
variables (change in blood glucose levels, change in BMI, change in total cholesterol
levels, and change in blood pressure) were constant across the studies, as the
WISEWOMAN program has a standard Minimal Data Element (MDE).
The WISEWOMAN program addresses racial/ethnic disparities in cardiovascular
disease. NonWhite women in the South Dakota WISEWOMAN program exhibit more
health disparities than White women. Systolic blood pressure change scores varied
significantly across ethnic groups. NonWhite women experienced less change in systolic
blood pressure, as compared to White women. Finkelstein et al. (2004) concluded that
BMI, blood pressure, total cholesterol, blood glucose, as well as smoking prevalence was
greater among minority populations than among the White population.
A woman’s age is suggestive of the overall change a woman will experience from
screening to rescreening. This research suggests that total cholesterol change scores
varied significantly across age groups. South Dakota women aged 49 years and older
experienced more cholesterol change than women 38 years and younger. This is in line
with the work of Feresu et al. (2008) who found that among Nebraska WISEWOMAN
participants, age was the most significant factor in determining cardiovascular risk.
Overall, the results of this dissertation did not confirm the findings of other
similar WISEWOMAN studies. Of the eight total WISEWOMAN studies that focused on
change in biomarkers, six of them demonstrated positive results in that the interventions
were effective. The methods used in previous WISEWOMAN studies differ greatly based
on location, sample size, demographics, random assignment, intervention intensity,
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longevity and funding level, as well as the overall analysis. The results of this
dissertation do not support the research hypotheses and therefore are not supportive of the
current WISEWOMAN intervention component in promoting change among
underinsured and uninsured women residing in South Dakota.
Limitations
The results of this study are limited in that regional and cultural differences, as
well as participation in the South Dakota WISEWOMAN program may influence
perceived barriers to intervention attendance and health behavior change. Women in the
more remote areas of the state are less likely to participate in the face to face intervention
sessions than those women residing in more urban areas (South Dakota Department of
Health, 2009). In addition, the sample was limited to participants eligible to participate in
the South Dakota WISEWOMAN cohort and subjects were not randomly assigned to
group (comparison vs. intervention). The implementation of the WISEWOMAN program
in this state did not take into account a woman’s readiness to change and differing levels
of risk. Participants were assigned to an LSI according to their bio-marker levels, not in
relation to a woman’s risk, perceived risk, and readiness to change. Many women do not
attend an LSI because they do not perceive their risk to be elevated.
Participants were advised to fast before blood tests, but no means of verification
was available. Consequently, some measurement error may have been introduced into
laboratory tests, thus increasing random fluctuation. Any such error would have been
randomly distributed between groups and should not have introduced systematic bias.
The results of this dissertation study did not take into account confounding
variables that were not measured or analyzed. The reality that attendance of intervention
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sessions is crowded out by other obligations highlights the difficulty of attracting
women to attend intervention sessions. In 2001, Krummel and colleagues recommended
that public health programs target broad environmental influences on health. Rural
communities are challenged in providing fresh fruits and vegetables in the local grocery
stores. These same communities also lack environments where women can walk safely in
extreme weather conditions. Nearly two-thirds of SD WISEWOMAN participants are
working (South Dakota Department of Labor, 2007), therefore making childcare an issue.
Other variables that were not taken into account include other co-occurring health issues,
motivation, cultural beliefs/norms, cost (both monetary and time), transportation,
weather, and support from family and friends.
Methodological issues in the sample for this research limit the external validity of
this study. Since clients were not randomly assigned to groups, unmeasured variables
could confound the results. Another limitation of the study is the absence of medication
histories for each participant. The South Dakota Department of Health or MaxTrac chose
not to include medications in the MDE (minimal data elements) that it collects because
all participants in need of medications were referred to the Department of Social Services
RX Access program.
American Indian data are lacking in this dissertation study because of a simple
billing issue. Indian Health Service (IHS) does not submit bills to the South Dakota
WISEWOMAN program for screening. If the program does not pay the bill, then the
woman can not be enrolled in the WISEWOMAN program. This is a relatively
straightforward problem to fix; however, it has been ongoing since the program began.
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Recommendations for Future Research
More research is needed in order to confirm or dispute the findings reported here.
A randomized experiment should be undertaken to test the assumption that selection bias
did not affect the conclusions of this observational study. Specifically, the possibility
that women who attended the lifestyle sessions were clinically, socially or
psychologically different from those who only participated in screening should be
investigated.
Recommendations for Action and Implications for Social Change
The results of this dissertation indicated that programs intending to promote
improved lifestyles among disadvantaged women should rely heavily on screenings to
identify diseases that otherwise would go undiagnosed. The data presented here do not
support continued reliance on the full WISEWOMAN program package, since the
lifestyle change sessions appear to not offer an incremental improvement in biomarkers.
Dissemination Plan
Dissertation results will be disseminated in a timely, responsible, and respectful
manner to the South Dakota WISEWOMAN program, the South Dakota Department of
Health, CDC, State of South Dakota legislators, as well as other stakeholders and
community coalitions that could be potentially impacted by the research results and
conclusions. The results will be shared via state and national poster/oral presentations,
peer reviewed journal articles, and special executive summaries.
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